Cardio Flashcards

1
Q

What are the shockable rhythms

A

ventricular fibrillation/pulseless ventricular tachycardia (VF/pulseless VT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the non shockable rhythms

A

asystole/pulseless-electrical activity (asystole/PEA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do you do when you defibrillate (how many shocks etc)

A

single shock for VF/pulseless VT followed by 2 minutes of CPR
or three successive shocks if the patient is a ‘monitored patient’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When do you give adrenaline in a cardiac arrest

A

1mg asap for non shockable rhythms
during VF/VT, 1mg given once chest compressions have restarted after third shock
repeat adrenaline every 3-5mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

when do you give amiodarone in cardiac arrest

A

300mg for patients in VF/pulseless VT after 3 shocks
further dose of 150g after 5 shocks
lidocaine can be used as an alternative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

when do you use thrombolytic drugs in cardiac arrest

A

if PE is suspected
give alteplase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the reversible causes of cardiac arrest

A

The ‘Hs’
Hypoxia
Hypovolaemia
Hyperkalaemia, hypokalaemia, hypoglycaemia, hypocalcaemia, acidaemia and other metabolic disorders
Hypothermia

The ‘Ts’
Thrombosis (coronary or pulmonary)
Tension pneumothorax
Tamponade - cardiac
Toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Person has cardiac arrest with shockable rhythm, what do you do

A

CPR 30:2
attach defib
assess rhythm
1 shock
continue CPR for 2 mins
reassess rhythm
repeat
3 shocks -> 1mg adrenaline,300mg amiodarone
5 shocks -> 150mg amiodarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Person has cardiac arrest with non-shockable rhythm, what do you do

A

1mg adrenaline
resume CPR for 2 mins
reassess rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does a raised troponin level in the context of chest pain suggest

A

MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the difference between unstable angina and NSTEMI

A

no elevation of troponin
however, troponin may take a few hours to rise so treated the same until known

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are classic symptoms of ACS

A

chest pain (central/left sided)
radiates to jaw or left arm
described as heavy, ‘like an elephant on my chest’
dyspnoea
sweating
nausea and vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What investigations do we do for chest pain

A

ECG
cardiac markers eg troponin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What ECG changes are linked to anterior STEMI and what artery

A

V1-V4 left anterior descending

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What ECG changes are linked to inferior STEMI and what artery

A

II, III, aVF right coronary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What ECG changes are linked to lateral STEMI and what artery

A

I, V5-V6 left circumflex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how do you treat ACS generally

A

in general = MONA:
morphine, oxygen, nitrates, aspirin

If NSTEMI, use risk tool eg GRACE to determine management, if high risk/unstable, do coronary angiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is secondary prevention of ACS

A

aspirin
a second antiplatelet if appropriate (e.g. clopidogrel)
a beta-blocker
an ACE inhibitor
a statin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are features of hypercalcaemia

A

‘bones, stones, groans and psychic moans’
corneal calcification
shortened QT interval on ECG
hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what can cause a prolonged QT interval

A

Drugs
amiodarone, sotalol, class 1a antiarrhythmic drugs
tricyclic antidepressants, fluoxetine
chloroquine
terfenadine
erythromycin

Other
electrolyte: hypocalcaemia, hypokalaemia, hypomagnesaemia
acute myocardial infarction
myocarditis
hypothermia
subarachnoid haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How do you treat VT/TdP

A

(in TdP) IV mag sulph first line to stabilise cardiac membrane

amiodarone

If drug therapy fails
electrophysiological study (EPS)
implant able cardioverter-defibrillator (ICD) - this is particularly indicated in patients with significantly impaired LV function

Give shock if unstable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What ECG changes are linked to posterior STEMI and what artery

A

V1-V3
Reciprocal changes of STEMI are typically seen:
horizontal ST depression
tall, broad R waves
upright T waves
dominant R wave in V2

Posterior infarction is confirmed by ST elevation and Q waves in posterior leads (V7-9)

Usually left circumflex, also right coronary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

‘widened QRS complexes and a notched morphology of the QRS complexes in the lateral leads’ what is it

A

left bundle branch block, prompts investigation for ACS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

‘Delta waves and a short PR-interval’

A

Wolff-Parkinson-White syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

‘New widening QRS complexes and an RSR’ pattern in V1’

A

right bundle branch block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

‘T-wave flattening and the appearance of U-waves’

A

hypokalaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what is acute management of heart failure

A

IV loop diuretics
e.g. furosemide or bumetanide
oxygen
can give nitrates if concomitant myocardial ischaemia, severe hypertension or regurgitant aortic or mitral valve disease

with resp failure -> CPAP

if hypotensive -> inotropic agents eg dobutamine

mechanical circulatory assistance
e.g. intra-aortic balloon counterpulsation or ventricular assist devices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

when should you stop beta blockers for heart failure

A

heart rate less than 50 beats per minute, second or third degree atrioventricular block, or shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

how do you manage VTE/PE

A

massive PE + unstable -> alteplase
otherwise -> DOAC (apixaban or rivaroxaban)
if significant renal impairment -> LMWH, unfractionated heparin or LMWH followed by vitamin K antagonist eg warfarin
if antiphospholipid syndrome -> LMWH followed by VKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

how long do you stay on anticoagulation for VTE/PE

A

If provoked, stop after 3 months (3-6 months if cancer)
if unprovoked, go up to 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

how do you manage broad complex tachycardia

A

Regular
assume ventricular tachycardia (unless previously confirmed SVT with bundle branch block)
loading dose of amiodarone followed by 24 hour infusion

Irregular
seek expert help. Possibilities include:
atrial fibrillation with bundle branch block - the most likely cause in a stable patient
atrial fibrillation with ventricular pre-excitation
torsade de pointes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

how do you manage narrow (<0.12s) complex tachycardia

A

Regular
vagal manoeuvres followed by IV adenosine
if the above is unsuccessful consider a diagnosis of atrial flutter and control rate (e.g. beta-blockers)

Irregular
probable atrial fibrillation
if onset < 48 hr consider electrical or chemical cardioversion
rate control: beta-blockers are usually first-line unless there is a contraindication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are side effects of loop diuretics

A

hypotension
hyponatraemia
hypokalaemia, hypomagnesaemia
hypochloraemic alkalosis
ototoxicity
hypocalcaemia
renal impairment (from dehydration + direct toxic effect)
hyperglycaemia (less common than with thiazides)
gout

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

what is stage 1 hypertension defined as?

A

Clinic BP >= 140/90 mmHg and subsequent ABPM daytime average or HBPM average BP >= 135/85 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

what is stage 2 hypertension defined as?

A

Clinic BP >= 160/100 mmHg and subsequent ABPM daytime average or HBPM average BP >= 150/95 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

what is stage 3 hypertension defined as?

A

Clinic systolic BP >= 180 mmHg, or clinic diastolic BP >= 120 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

When do you treat hypertension

A

> =135/85 - only if they are <80 and have one of:
-target organ damage
-established cardiovascular disease
-renal disease
-diabetes
-10 year cardiovascular risk >=10%

> =150/95 - always treat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

how do you manage hypertension

A

lifestyle advice:
-low salt diet <6g a day ideally 3g
-reduce caffeine intake
-stop smoking etc

If <55 or T2DM
start with ACEi or ARB
then add CCB or thiazide like diuretic
then add both
then if K+<4.5 add low dose spironolactone, if >4.5 add alpha or beta blocker

If >55 and no T2DM or african/afro caribbean
start with CCB
add ACEi/ARB or thiazide like diuretic
then add both
then if K+<4.5 add low dose spironolactone, if >4.5 add alpha or beta blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What are blood pressure targets

A

<80 clinic=140/90, ABPM/HBPM = 135/85
>80 clinic=150/90, ABPM/HBPM = 145/85

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is CHA2DS2-VASc scoring system

A

Used to determine the need to anticoagulate a patient in atrial fibrillation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What is NYHA scoring system

A

Heart failure severity scale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

DAS28

A

Measure of disease activity in rheumatoid arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Child-Pugh classification

A

A scoring system used to assess the severity of liver cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Wells score

A

Helps estimate the risk of a patient having a deep vein thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

MMSE

A

Mini-mental state examination - used to assess cognitive impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

HAD

A

Hospital Anxiety and Depression (HAD) scale - assesses severity of anxiety and depression symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

PHQ-9

A

Patient Health Questionnaire - assesses severity of depression symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

GAD-7

A

Used as a screening tool and severity measure for generalised anxiety disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Edinburgh Postnatal Depression Score

A

Used to screen for postnatal depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

SCOFF

A

Questionnaire used to detect eating disorders and aid treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

AUDIT, CAGE, FAST

A

Alcohol screening tool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

CURB-65

A

Used to assess the prognosis of a patient with pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Epworth Sleepiness Scale

A

Used in the assessment of suspected obstructive sleep apnoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

IPSS

A

International prostate symptom score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Gleason score

A

Indicates prognosis in prostate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

APGAR

A

Assesses the health of a newborn immediately after birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Bishop score

A

Used to help assess the whether induction of labour will be required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Waterlow score

A

Assesses the risk of a patient developing a pressure sore

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

FRAX

A

Risk assessment tool developed by WHO which calculates a patients 10-year risk of developing an osteoporosis related fracture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Ranson criteria

A

Acute pancreatitis scoring system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

MUST

A

Malnutrition scoring system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What are features of complete heart block

A

syncope
heart failure
regular bradycardia (30-50 bpm)
wide pulse pressure
JVP: cannon waves in neck
variable intensity of S1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What is first degree heart block

A

PR interval > 0.2 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

What is second degree heart block

A

type 1 (Mobitz I, Wenckebach): progressive prolongation of the PR interval until a dropped beat occurs
type 2 (Mobitz II): PR interval is constant but the P wave is often not followed by a QRS complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

What is third (complete) degree heart block

A

there is no association between the P waves and QRS complexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

infarction of what vessel can cause complete heart block post MI

A

right coronary artery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

How do you manage STEMI

A

If STEMI,
aspirin 300mg

percutaneous coronary intervention (PCI) if presenting <12 hours and can be given within 120 mins of the time that fibrinolysis can be given (basically you want to give PCI but would consider fibrinolysis if you cant give it in time. if fibrinolysis, also give antithrombin drug and do ECG after 60-90 mins to see if changes have resolved)

PCI is given with drug eluting stent through radial access preferred over femoral

During PCI, unfractionated heparin with bailout glycoprotein IIb/IIIa inhibitor (GPI) is given

second antiplatelet should be given with aspirin eg clopidogrel (if taking oral anticoagulant), prasugrel (if not taking oral anticoagulant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

How do you manage NSTEMI

A

aspirin + fondaparinux (if no immediate PCI)
estimate 6 month mortality eg GRACE

low risk (<3%) - ticagrelor or clopidogrel (if high risk of bleeding)

higher risk (>3%) - Offer PCI (immediately if unstable otherwise within 72 hours)
give prasugrel or ticagrelor
give unfractionated heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

how do you treat bradycardia

A

IV atropine 5oomcg
then use again up to 3mg
then transcutaneous pacing
then isoprenaline/adrenaline infusion
then transvenous pacing with specialist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

what are side effects of ACEi

A

cough
angioedema
hyperkalaemia
first dose hypokalaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

what are some cautions and contraindications for ACEi

A

pregnancy and breastfeeding - avoid
renovascular disease - may result in renal impairment
aortic stenosis - may result in hypotension
hereditary of idiopathic angioedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

what electrolytes change when using an ACEi

A

creatinine
potassium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

what is an acceptable change for creatinine/potassium when using ACEi

A

acceptable changes are an increase in serum creatinine, up to 30% from baseline and an increase in potassium up to 5.5 mmol/l.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

what condition can using an ACEi with result in significant renal impairment

A

bilateral renal artery stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

how would you manage angina pectoris

A

aspirin + statin for every patient
sublingual glyceryl trinitrate to abort angina attacks

beta blocker/CCB first line - if CCB used solely, a rate limiting one such as verapamil or diltiazem should be used - if used in combo, use a longer acting dihydropyridine CCB eg amlodipine, modified release nifedipine

if poor response, increase to max tolerated dose

if still symptomatic after monotherapy add the other thing (ie CCB/beta blocker) then if still symptomatic add one of
long acting nitrate
ivabradine
nicorandil
ranozaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

How do people using nitrates avoid nitrate tolerance

A

use an assymetric dosing interval if using standard release isosorbide mononitrate which allows a daily nitrate free time of 10-14 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

what are features of acute pericarditis

A

chest pain: may be pleuritic. Is often relieved by sitting forwards
other symptoms include a non-productive cough, dyspnoea and flu-like symptoms
pericardial rub

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

what do you see on ECG for acute pericarditis

A

widespread changes
‘saddle shaped’ ST elevation
PR depression (most specific for acute pericarditis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

what investigations would you do for acute pericarditis

A

ECG
transthoracic echocardiography
bloods - inflam markers, troponin for possible myopericarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

how do you manage acute pericarditis

A

mainly outpatients unless fever >38 or high troponin
treat underlying cause
avoid physical activity
combination of NSAID and colchicine used until symptoms go or inflam markers go down followed by tapering of dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

what is mitral stenosis

A

describes the obstruction of blood flow across the mitral valve from the left atrium to the left ventricle leading to increased pressure within the left atrium, pulmonary vasculature and right side of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

what causes mitral stenosis

A

rheumatic fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

what are features of mitral stenosis

A

dyspnoea - increased left atrial pressure -> pulmonary venous hypertension
haemoptysis
mid-late diastolic murmur (best heard on expiration)
loud S1
opening snap - indicates mitral valve leaflets are still mobile
low volume pulse
malar flush
atrial fib - secondary to increased left atrial pressure -> left atrial enlargement

when severe - length of murmur increases, opening snap becomes closer to S2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

what do you see on xray of mitral stenosis

A

possible left atrial enlargement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

how do you manage mitral stenosis

A

asymptomatic - monitor
symptomatic - percutaneous mitral balloon valvotomy, mitral valve surgery
associated aFib - require anticoagulation - usually warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

how do you deal with severe airway obstruction (emergency setting)

A

give up to 5 back blows
give up to 5 abdominal thrusts (pressing forcibly into the upper abdominal area with an upward moment)
keep continuing above cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

What is the pulmonary embolism rule out criteria (PERC)

A

you do it when you have a low suspicion (<15% probability) of PE but just want reassurance.
All criteria must be negative to rule it out
negative test reduces probability to <2%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

What is the 2 level Wells score and how do you manage the patient

A

you do it if PE is suspected
>4 points means its likely, <4 means unlikely

if likely
arrange immediate CTPA
if there is a delay in doing this then interim anticoagulation should be given (DOAC)
if positive result, PE confirmed
if negative, consider proximal leg vein US scan if DVT expected

If unlikely
arrange a D dimer test
if positive arrange immediate CTPA (give anticoag if delay)
If negative, PE is unlikely so stop anticoags and consider an alternative diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

When would you do V/Q scan over CTPA

A

if there is renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

What ecg changes could you see in PE

A

S1Q3T3 - large S wave in lead I, a large Q wave in lead III and an inverted T wave in lead III (RARE)
RBBB and right axis deviation
sinus tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

What xray changes do you see in PE

A

usually normal but could see wedge shaped opacification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

how do you investigate chronic heart failure

A

first line - N-terminal pro-B-type natriuretic peptide (NT-proBNP) blood test
if high (>2000pg/ml) - arrange specialist assessment including transthoracic echo within 2 weeks
if raised (400-2000 pg/ml) do the same within 6 weeks

if levels are ‘high’ arrange specialist assessment (including transthoracic echocardiography) within 2 weeks
if levels are ‘raised’ arrange specialist assessment (including transthoracic echocardiography) echocardiogram within 6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

how do you decide whether to use anticoagulation for aFib

A

use CHA2DS2-VASc score

C Congestive heart failure 1
H Hypertension (or treated hypertension) 1
A2 Age >= 75 years 2
Age 65-74 years 1
D Diabetes 1
S2 Prior Stroke, TIA or thromboembolism 2
V Vascular disease (including ischaemic heart disease and peripheral arterial disease) 1
S Sex (female) 1

0 = no treatment
1 = males - consider treatment, females no
>=2 = offer anticoag

if no treatment, do transthoracic echo to exclude valvular heart disease

Use DOACs, warfarin second line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

what is atrial flutter and what do you see

A

a succession of rapid atrial depolarisation waves.
‘sawtooth appearance’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

how do you manage atrial flutter

A

radiofrequency ablation of the tricuspid valve isthmus is curative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

what is the triad for cardiac tamponade + what are other features

A

Becks Triad:
hypotension
raised JVP
muffled heart sounds

dyspnoea
tachycardia
absent Y decent on JVP
pulsus paradoxus - abnormally large drop in BP during inspiration
electrical alternans on ECG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

What are the differences between cardiac tamponade and constrictive pericarditis

A

1) JVP
CT = Absent Y descent
CP = X + Y present
2) Pulsus paradoxus
CT = Present
CP = Absent
3) Kussmaul’s sign
CT = Rare
CP = Present
4) Characteristic features
CP = Pericardial calcification on CXR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

how do you manage cardiac tamponade

A

urgent pericardiocentesis (pericardial needle aspiration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

what are features of takayasu’s arteritis

A

systemic features of a vasculitis e.g. malaise, headache
unequal blood pressure in the upper limbs
carotid bruit and tenderness
absent or weak peripheral pulses
upper and lower limb claudication on exertion
aortic regurgitation (around 20%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

What other condition is takayasu’s arteritis associated with

A

renal artery stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

how do you investigate takayasu’s arteritis

A

magnetic resonance angiography (MRA) or CT angiography (CTA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

how do you manage takayasu’s arteritis

A

steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

What ecg changes do we see with hypothermia

A

bradycardia
‘J’ wave (Osborne waves) - small hump at the end of the QRS complex
first degree heart block
long QT interval
atrial and ventricular arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

what are features of buergers disease

A

Young male smoker with symptoms similar to limb ischaemia - think Buerger’s disease

extremity ischaemia
intermittent claudication
ischaemic ulcers
superficial thrombophlebitis
Raynaud’s phenomenon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

what are features of tension pneumothorax

A

Severe respiratory distress, tracheal deviation, unilateral absent breath sounds, and haemodynamic instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

what are features of hypokalaemia

A

U waves
small or absent T waves (occasionally inversion)
prolong PR interval
ST depression
long QT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

what is aortic regurgitation

A

leaking of aortic valve causing blood flow in reverse direction during ventricular diastole

caused by aortic root disease or valve disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

what are acute valvular causes of aortic regurg

A

infective endocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

what are chronic valvular causes of aortic regurg

A

rheumatic fever: the most common cause in the developing world
calcific valve disease
connective tissue diseases e.g. rheumatoid arthritis/SLE
bicuspid aortic valve (affects both the valves and the aortic root)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

what are chronic aortic root causes of aortic regurg

A

bicuspid aortic valve (affects both the valves and the aortic root)
spondylarthropathies (e.g. ankylosing spondylitis)
hypertension
syphilis
Marfan’s, Ehler-Danlos syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

what are acute aortic root causes of aortic regurg

A

aortic dissection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

what are features of aortic regurg

A

early diastolic murmur: intensity of the murmur is increased by the handgrip manoeuvre
collapsing pulse
wide pulse pressure
Quincke’s sign (nailbed pulsation)
De Musset’s sign (head bobbing)
mid-diastolic Austin-Flint murmur in severe AR - due to partial closure of the anterior mitral valve cusps caused by the regurgitation streams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

how do you investigate aortic regurg

A

echocardiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

how do you manage aortic regurg

A

medical management of associated heart failure
surgery for symptomatic patients or asymptomatic with LV dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

how do thiazide diuretics work

A

inhibiting sodium reabsorption at the beginning of the distal convoluted tubule (DCT) by blocking the thiazide-sensitive Na+-Clˆ’ symporter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

what are side effects of thiazide diuretics

A

dehydration
postural hypotension
hypokalaemia
due to increased delivery of sodium to the distal part of the distal convoluted tubule → increased sodium reabsorption in exchange for potassium and hydrogen ions
hyponatraemia
hypercalcaemia
the flip side of this is hypocalciuria, which may be useful in reducing the incidence of renal stones
gout
impaired glucose tolerance
impotence

thrombocytopaenia
agranulocytosis
photosensitivity rash
pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

when is cardioversion used for Afib

A

if patient is unstable
electrical or pharmacological cardioversion as an elective procedure where a rhythm control strategy is preferred.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

how is cardioversion used when patient has Afib

A

synchronised to R wave to prevent delivery of a shock during the vulnerable period of cardiac repolarisation when ventricular fibrillation can be induced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

how do you manage Afib

A

<48 hours - patient is heparinised, put on lifelong anticoagulants if they have risk factors
otherwise can be cardioverted using electrical ‘DC’ cardioversion or pharmacologically with amiodarone

> 48 hours - anticoags given for >3 weeks prior to cardioversion or do a transoesophageal echo to exclude left atrial appendage thrombus
then anticoags for >4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

what are features of Hypertrophic obstructive cardiomyopathy (HOCM)

A

often asymptomatic
exertional dyspnoea
angina
syncope
typically following exercise
due to subaortic hypertrophy of the ventricular septum, resulting in functional aortic stenosis

sudden death (most commonly due to ventricular arrhythmias), arrhythmias, heart failure
jerky pulse, large ‘a’ waves, double apex beat

systolic murmurs
ejection systolic murmur: due to left ventricular outflow tract obstruction. Increases with Valsalva manoeuvre and decreases on squatting
pansystolic murmur: due to systolic anterior motion of the mitral valve → mitral regurgitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

What echo findings do you see in HOCM

A

MR SAM ASH
mitral regurgitation (MR)
systolic anterior motion (SAM) of the anterior mitral valve leaflet
asymmetric hypertrophy (ASH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

What ecg changes do you see in HOCM

A

left ventricular hypertrophy
non-specific ST segment and T-wave abnormalities, progressive T wave inversion may be seen
deep Q waves
atrial fibrillation may occasionally be seen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

what investigation do you do for cardiac tamponade

A

echo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

which valve is most commonly affected in infective endocarditis

A

mitral valve (tricuspid in IVDU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

What is the most common cause of infective endocarditis for
1)all patients
2)dental patients
3)<2 months after prosthetic valve surgery

A

1 - staph aureus
2 - staph viridans
3 - staph epidermidis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

how do you manage hypothermia

A

Removing the patient from the cold environment and removing any wet/cold clothing,
Warming the body with blankets
Securing the airway and monitoring breathing,
If the patient is not responding well to passive warming, you may consider maintaining circulation using warm IV fluids or applying forced warm air directly to the patient’s body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

You warm a patient with hypothermia but they go into shock, what happened?

A

rapid rewarming

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

What are features of constrictive pericarditis

A

dyspnoea
right heart failure: elevated JVP, ascites, oedema, hepatomegaly
JVP shows prominent x and y descent
pericardial knock - loud S3
Kussmaul’s sign is positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

what do you see on xray of constrictive pericarditis

A

pericardial calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

What are features of rheumatic fever

A

Recent sore throat, rash, arthritis, murmur → ?rheumatic fever

erythema marginatum
Sydenham’s chorea: this is often a late feature
polyarthritis
carditis and valvulitis (eg, pancarditis)
subcutaneous nodules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

how do you manage rheumatic fever

A

oral penicillin V
NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

what other investigation should you always do with PE

A

xray to exclude pneumothorax, pleural effusion etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

how do you manage HOCM

A

Amiodarone
Beta-blockers or verapamil for symptoms
Cardioverter defibrillator
Dual chamber pacemaker
Endocarditis prophylaxis*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

what drugs do you avoid in HOCM

A

nitrates
ACE-inhibitors
inotropes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

what are features of coarctation of the aorta

A

infancy: heart failure
adult: hypertension
radio-femoral delay
mid systolic murmur, maximal over the back
apical click from the aortic valve
notching of the inferior border of the ribs (due to collateral vessels) is not seen in young children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

how do we investigate palpitations

A

12 lead ecg
tfts for thyrotoxicosis
u’s and e’s - potassium
FBC

then you want to capture episodic arrythmias using Holter monitoring
if no abnormality found, can do external loop recorder or implantable loop recorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

What is adenosine most commonly used for?

A

A: Adenosine is most commonly used to terminate supraventricular tachycardias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

Q: Which agents enhance the effects of adenosine?

A

A: The effects of adenosine are enhanced by dipyridamole (antiplatelet agent).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

Q: Which agents block the effects of adenosine?

A

A: The effects of adenosine are blocked by theophyllines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

Q: Why should adenosine be avoided in asthmatics?

A

A: Adenosine should be avoided in asthmatics due to possible bronchospasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
142
Q

Q: What is the mechanism of action of adenosine?

A

A: Adenosine causes transient heart block in the AV node by acting as an agonist of the A1 receptor in the atrioventricular node, inhibiting adenylyl cyclase, reducing cAMP, and causing hyperpolarization by increasing outward potassium flux.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
143
Q

Q: How long is the half-life of adenosine?

A

A: The half-life of adenosine is about 8-10 seconds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

Q: How should adenosine be administered due to its short half-life?

A

A: Adenosine should ideally be infused via a large-calibre cannula due to its short half-life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
145
Q

Q: What are some adverse effects of adenosine?

A

A: Adverse effects of adenosine include chest pain, bronchospasm, transient flushing, and enhanced conduction down accessory pathways, resulting in increased ventricular rate (e.g., WPW syndrome).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
146
Q

Q: What is the 1st line antiplatelet treatment for acute coronary syndrome (medically treated)?

A

A: Aspirin (lifelong) & ticagrelor (12 months).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
147
Q

Q: What is the 2nd line antiplatelet treatment for acute coronary syndrome if aspirin is contraindicated?

A

A: Clopidogrel (lifelong).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
148
Q

Q: What is the 1st line antiplatelet treatment for percutaneous coronary intervention?

A

A: Aspirin (lifelong) & prasugrel or ticagrelor (12 months).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
149
Q

Q: What is the 2nd line antiplatelet treatment for percutaneous coronary intervention if aspirin is contraindicated?

A

A: Clopidogrel (lifelong).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
150
Q

Q: What is the 1st line antiplatelet treatment for TIA?

A

A: Clopidogrel (lifelong).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
151
Q

Q: What is the 2nd line antiplatelet treatment for TIA if clopidogrel is contraindicated or not tolerated?

A

A: Aspirin (lifelong) & dipyridamole (lifelong).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
152
Q

Q: What is the 1st line antiplatelet treatment for ischaemic stroke?

A

A: Clopidogrel (lifelong).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
153
Q

Q: What is the 2nd line antiplatelet treatment for ischaemic stroke if clopidogrel is contraindicated or not tolerated?

A

A: Aspirin (lifelong) & dipyridamole (lifelong).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
154
Q

Q: What is the 1st line antiplatelet treatment for peripheral arterial disease?

A

A: Clopidogrel (lifelong).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
155
Q

Q: What is the 2nd line antiplatelet treatment for peripheral arterial disease if clopidogrel is contraindicated or not tolerated?

A

A: Aspirin (lifelong).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
156
Q

Q: What is aortic dissection?

A

A: Aortic dissection is a rare but serious cause of chest pain characterized by a tear in the tunica intima of the wall of the aorta.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
157
Q

Q: What is the most important risk factor for aortic dissection?

A

A: Hypertension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
158
Q

Q: What are some conditions associated with aortic dissection?

A

A: Hypertension, trauma, bicuspid aortic valve, Marfan’s syndrome, Ehlers-Danlos syndrome, Turner’s syndrome, Noonan’s syndrome, pregnancy, and syphilis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
159
Q

Q: How is the chest/back pain in aortic dissection typically described?

A

A: The pain is typically severe, sharp, and tearing in nature, and it is maximal at onset.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
160
Q

Q: What type of pain is more common in type A dissection versus type B dissection?

A

A: Chest pain is more common in type A dissection, while upper back pain is more common in type B dissection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
161
Q

Q: What are some pulse-related features of aortic dissection?

A

A: Pulse deficit (weak or absent carotid, brachial, or femoral pulse) and variation in systolic blood pressure (>20 mmHg) between the arms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
162
Q

Q: What are some complications of aortic dissection involving specific arteries?

A

A: Coronary arteries can lead to angina, spinal arteries can lead to paraplegia, and distal aorta can lead to limb ischemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
163
Q

Q: What are the typical ECG findings in aortic dissection?

A

A: The majority of patients have no or non-specific ECG changes, but a minority may show ST-segment elevation in the inferior leads.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
164
Q

Q: Describe the Stanford classification of aortic dissection.

A

A: Type A involves the ascending aorta (2/3 of cases) and Type B involves the descending aorta, distal to the left subclavian origin (1/3 of cases).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
165
Q

Q: Describe the DeBakey classification of aortic dissection.

A

A: Type I originates in the ascending aorta and propagates to at least the aortic arch and possibly beyond; Type II originates in and is confined to the ascending aorta; Type III originates in the descending aorta, rarely extends proximally but will extend distally.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
166
Q

Q: What chest X-ray finding is associated with aortic dissection?

A

A: Widened mediastinum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
167
Q

Q: What is the investigation of choice for aortic dissection in stable patients?

A

A: CT angiography of the chest, abdomen, and pelvis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
168
Q

Q: What key finding on CT angiography helps diagnose aortic dissection?

A

A: A false lumen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
169
Q

Q: Which investigation is more suitable for unstable patients with aortic dissection?

A

A: Transoesophageal echocardiography (TOE).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
170
Q

Q: What is the management for type A aortic dissection?

A

A: Surgical management, with blood pressure controlled to a target systolic of 100-120 mmHg while awaiting intervention.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
171
Q

Q: What is the management for type B aortic dissection?

A

A: Conservative management, including bed rest and blood pressure reduction with IV labetalol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
172
Q

Q: What are the complications of a backward tear in aortic dissection?

A

A: Aortic incompetence/regurgitation and myocardial infarction (often with an inferior pattern due to right coronary involvement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
173
Q

Q: What are the complications of a forward tear in aortic dissection?

A

A: Unequal arm pulses and blood pressure, stroke, and renal failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
174
Q

Q: What are the clinical features of symptomatic aortic stenosis?

A

A: Chest pain, dyspnoea, syncope/presyncope (e.g., exertional dizziness), and murmur.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
175
Q

Q: What type of murmur is classically seen in aortic stenosis and how does it radiate?

A

A: An ejection systolic murmur (ESM) that classically radiates to the carotids and is decreased following the Valsalva manoeuvre.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
176
Q

Q: What are the features of severe aortic stenosis?

A

A: Narrow pulse pressure, slow rising pulse, delayed ESM, soft/absent S2, S4, thrill, duration of murmur, and left ventricular hypertrophy or failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
177
Q

Q: What is the most common cause of aortic stenosis in older patients (>65 years)?

A

A: Degenerative calcification.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
178
Q

Q: What is the most common cause of aortic stenosis in younger patients (<65 years)?

A

A: Bicuspid aortic valve.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
179
Q

Q: When should valve replacement be considered in aortic stenosis?

A

A: If symptomatic or if asymptomatic with a valvular gradient > 40 mmHg and features such as left ventricular systolic dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
180
Q

Q: What are the options for aortic valve replacement (AVR)?

A

A: Surgical AVR, transcatheter AVR (TAVR), and balloon valvuloplasty.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
181
Q

Q: Which type of AVR is the treatment of choice for young, low/medium operative risk patients?

A

A: Surgical AVR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
182
Q

Q: When is transcatheter AVR (TAVR) typically used?

A

A: For patients with a high operative risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
183
Q

Q: What is arrhythmogenic right ventricular cardiomyopathy (ARVC)?

A

A: ARVC, also known as arrhythmogenic right ventricular dysplasia (ARVD), is an inherited cardiovascular disease that may present with syncope or sudden cardiac death and is the second most common cause of sudden cardiac death in the young after hypertrophic cardiomyopathy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
184
Q

Q: What is the inheritance pattern of ARVC?

A

A: Autosomal dominant with variable expression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
185
Q

Q: What happens to the right ventricular myocardium in ARVC?

A

A: It is replaced by fatty and fibrofatty tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
186
Q

Q: What are the common presentations of ARVC?

A

A: Palpitations, syncope, and sudden cardiac death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
187
Q

Q: What are the typical ECG findings in ARVC?

A

A: T wave inversion in V1-3 and an epsilon wave, which is a terminal notch in the QRS complex, found in about 50% of those with ARVC.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
188
Q

Q: What echocardiographic changes might be seen in ARVC?

A

A: Subtle changes in the early stages, but may show an enlarged, hypokinetic right ventricle with a thin free wall.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
189
Q

Q: What are the management options for ARVC?

A

A: Drugs (sotalol), catheter ablation to prevent ventricular tachycardia, and implantable cardioverter-defibrillator (ICD).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
190
Q

Q: What is the most common sustained cardiac arrhythmia?

A

A: Atrial fibrillation (AF).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
191
Q

Q: What is the most important aspect of managing patients with AF?

A

A: Reducing the increased risk of stroke.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
192
Q

Q: How is AF classified?

A

A: First detected episode, paroxysmal, persistent, or permanent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
193
Q

Q: What is paroxysmal AF?

A

A: AF that terminates spontaneously and lasts less than 7 days (typically < 24 hours).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
194
Q

Q: What is persistent AF?

A

A: AF that is not self-terminating and usually lasts greater than 7 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
195
Q

Q: What is permanent AF?

A

A: Continuous AF that cannot be cardioverted or when attempts to do so are deemed inappropriate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
196
Q

Q: What are the symptoms of AF?

A

A: Palpitations, dyspnoea, and chest pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
197
Q

Q: What investigation is essential to diagnose AF?

A

A: ECG (electrocardiogram).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
198
Q

Q: What are the two key parts of managing AF?

A

A: Rate/rhythm control and reducing stroke risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
199
Q

Q: What is the aim of rate control in AF management?

A

A: To slow the rate down to avoid negative effects on cardiac function while accepting an irregular pulse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
200
Q

Q: What is the aim of rhythm control in AF management?

A

A: To get the patient back into, and maintain, normal sinus rhythm through cardioversion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
201
Q

Q: What is the first-line treatment for rate control in AF?

A

A: A beta-blocker or a rate-limiting calcium channel blocker (e.g., diltiazem).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
202
Q

Q: What combination therapy does NICE recommend if one drug does not adequately control the rate in AF?

A

A: Any 2 of the following: a beta-blocker, diltiazem, digoxin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
203
Q

Q: When is rhythm control considered in AF management?

A

A: For specific situations such as coexistent heart failure, first onset AF, or if there is an obvious reversible cause, and if symptoms/heart rate fail to settle with rate control.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
204
Q

Q: Why is it important to anticoagulate patients before attempting cardioversion?

A

A: To reduce the risk of embolism leading to stroke when the patient switches from AF to sinus rhythm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
205
Q

Q: What does a CHA2DS2-VASc score of 0 indicate for anticoagulation?

A

A: No treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
206
Q

Q: What does a CHA2DS2-VASc score of 1 indicate for anticoagulation in males and females?

A

A: Males: Consider anticoagulation; Females: No treatment (score of 1 is due to gender).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
207
Q

Q: What does a CHA2DS2-VASc score of 2 or more indicate for anticoagulation?

A

A: Offer anticoagulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
208
Q

Q: What anticoagulation options does NICE recommend for AF patients?

A

A: Warfarin and novel oral anticoagulants (NOACs).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
209
Q

Question: What should be ensured if a CHA2DS2-VASc score suggests no need for anticoagulation?

A

Answer: A transthoracic echocardiogram should be done to exclude valvular heart disease, which is an absolute indication for anticoagulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
210
Q

Question: What is the ORBIT scoring system used for in AF?

A

Answer: The ORBIT scoring system is used to assess bleeding risk before starting anticoagulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
211
Q

Question: What does the ORBIT score indicate about bleeding risk?

A

0-2: Low risk (2.4 bleeds per 100 patient-years)
3: Medium risk (4.7 bleeds per 100 patient-years)
4-7: High risk (8.1 bleeds per 100 patient-years)

212
Q

Question: Which anticoagulants are recommended by NICE for reducing stroke risk in AF?

A

Answer: Apixaban, dabigatran, edoxaban, and rivaroxaban.

213
Q

Question: What is the current first-line anticoagulant for AF, and why?

A

Answer: Direct oral anticoagulants (DOACs) are the first-line choice because they do not require regular INR monitoring.

214
Q

Question: When is warfarin used in AF treatment?

A

Answer: Warfarin is used second-line, in patients where a DOAC is contraindicated or not tolerated.

215
Q

Question: Is aspirin recommended for reducing stroke risk in AF?

A

Answer: No, aspirin is not recommended for reducing stroke risk in patients with AF.

216
Q

Question: Why is it important to recognise and treat atrial fibrillation (AF) in patients who have had a stroke or TIA?

A

Answer: Atrial fibrillation is a key risk factor for ischemic stroke, and recognizing and treating it is essential for reducing the risk of future strokes.

217
Q

Question: What should be excluded before starting anticoagulation or antiplatelet therapy following a stroke or TIA?

A

Answer: A haemorrhage should be excluded before starting any anticoagulation or antiplatelet therapy.

218
Q

Question: What anticoagulation options does NICE recommend for long-term stroke prevention in patients with AF following a stroke or TIA?

A

Answer: NICE recommends warfarin or a direct thrombin or factor Xa inhibitor for long-term stroke prevention.

219
Q

Question: When should anticoagulation therapy be started following a TIA?

A

Answer: Anticoagulation for AF should start immediately following a TIA, once imaging has excluded haemorrhage.

220
Q

Question: When should anticoagulation therapy be started following an acute stroke?

A

Answer: Anticoagulation therapy should be started 2 weeks after an acute stroke, in the absence of haemorrhage. Antiplatelet therapy should be given in the intervening period.

221
Q

Question: When should the initiation of anticoagulation be delayed following a stroke?

A

Answer: Anticoagulation should be delayed if imaging shows a very large cerebral infarction.

222
Q

Question: What should be done if a patient presents acutely with atrial fibrillation (AF) and has signs of haemodynamic instability?

A

Answer: The patient should be electrically cardioverted, following the peri-arrest tachycardia guidelines.

223
Q

Question: How is the management of atrial fibrillation (AF) determined in haemodynamically stable patients?

A

If AF has been present for < 48 hours: rate or rhythm control is used.
If AF has been present for ≥ 48 hours or the onset is uncertain: rate control is used.
For long-term rhythm control, delay cardioversion until the patient has been maintained on therapeutic anticoagulation for at least 3 weeks.

224
Q

Question: When should rate control be offered as the first-line treatment strategy for atrial fibrillation (AF)?

A

Answer: Rate control should be the first-line strategy except for patients who:

Have a reversible cause for AF.
Have heart failure primarily caused by AF.
Have new-onset AF (< 48 hours).
Have atrial flutter suitable for ablation to restore sinus rhythm.
For whom rhythm control is more appropriate based on clinical judgement.

225
Q

Question: What medications are commonly used to control heart rate in patients with atrial fibrillation (AF)?

A

Beta-blockers (contraindicated in asthma).
Calcium channel blockers.
Digoxin (not first-line due to less effectiveness during exercise, only used if physical exercise is minimal or other options are contraindicated, may be used if heart failure is coexistent).

226
Q

Question: What medications are used for rhythm control in atrial fibrillation (AF)?

A

Beta-blockers.
Dronedarone (second-line after cardioversion).
Amiodarone (especially if coexisting heart failure).

227
Q

Question: When should catheter ablation be considered in atrial fibrillation (AF) management?

A

Answer: Catheter ablation is recommended for patients who have not responded to or wish to avoid antiarrhythmic medications.

228
Q

Question: What is the goal of catheter ablation in atrial fibrillation (AF)?

A

Answer: The goal is to ablate the faulty electrical pathways causing AF, typically due to aberrant electrical activity between the pulmonary veins and left atrium.

229
Q

Question: What are the key technical aspects of catheter ablation in AF?

A

Answer: The procedure is performed percutaneously, typically via the groin. Radiofrequency (using heat) or cryotherapy can be used to ablate the tissue.

230
Q

Question: When should anticoagulation therapy be used in patients undergoing catheter ablation for atrial fibrillation (AF)?

A

Answer: Anticoagulation should be used 4 weeks before and during the procedure.

231
Q

Question: Does catheter ablation reduce the stroke risk in atrial fibrillation (AF) patients?

A

Answer: No, catheter ablation controls the rhythm but does not reduce stroke risk. Patients still require anticoagulation according to their CHA2DS2-VASc score.

232
Q

Question: What is the recommended duration of anticoagulation after catheter ablation for atrial fibrillation (AF)?

A

If CHA2DS2-VASc score = 0: 2 months of anticoagulation is recommended.
If CHA2DS2-VASc score > 1: long-term anticoagulation is recommended.

233
Q

Question: What are notable complications of catheter ablation for atrial fibrillation (AF)?

A

Cardiac tamponade.
Stroke.
Pulmonary vein stenosis.

234
Q

Question: What is the most common primary cardiac tumour?

A

Answer: Atrial myxoma.

235
Q

Question: Where do most atrial myxomas occur?

A

Answer: 75% occur in the left atrium, most commonly attached to the fossa ovalis.

236
Q

Question: In which gender are atrial myxomas more common?

A

Answer: Atrial myxomas are more common in females.

237
Q

Question: What systemic symptoms can be seen in a patient with atrial myxoma?

A

Dyspnoea
Fatigue
Weight loss
Pyrexia of unknown origin
Clubbing

238
Q

Question: What complications can occur due to atrial myxoma?

A

Answer: Emboli.

239
Q

Question: What heart rhythm disturbance is commonly seen in atrial myxoma?

A

Answer: Atrial fibrillation.

240
Q

Question: What characteristic heart sound might be heard in a patient with atrial myxoma?

A

Answer: A mid-diastolic murmur, often described as a “tumour plop.”

241
Q

Question: What does an echocardiogram typically show in a patient with atrial myxoma?

A

Answer: A pedunculated, heterogeneous mass typically attached to the fossa ovalis region of the interatrial septum.

242
Q

Question: What is the most common congenital heart defect found in adulthood?

A

Answer: Atrial septal defects (ASDs).

243
Q

Question: What are the two types of atrial septal defects (ASDs)?

A

Answer: Ostium secundum and ostium primum.

244
Q

Question: Which type of atrial septal defect (ASD) is the most common?

A

Answer: Ostium secundum.

245
Q

Question: What characteristic heart murmur is heard in patients with an atrial septal defect (ASD)?

A

Answer: An ejection systolic murmur with fixed splitting of S2.

246
Q

Question: What complication can occur in patients with atrial septal defects (ASDs) related to embolism?

A

Answer: Embolism may pass from the venous system to the left side of the heart, potentially causing a stroke.

247
Q

Question: What is heart block (atrioventricular (AV) block)?

A

Answer: Heart block is impaired electrical conduction between the atria and ventricles.

248
Q

Question: How many types of atrioventricular (AV) block are there?

A

Answer: There are three types:

First-degree heart block
Second-degree heart block (Type 1 and Type 2)
Third-degree (complete) heart block

249
Q

Question: What is characteristic of first-degree heart block?

A

Answer: The PR interval is > 0.2 seconds. Asymptomatic first-degree heart block is relatively common and does not need treatment.

250
Q

Question: What is characteristic of second-degree heart block, type 1 (Mobitz I, Wenckebach)?

A

Answer: There is progressive prolongation of the PR interval until a dropped beat occurs.

251
Q

Question: What is characteristic of second-degree heart block, type 2 (Mobitz II)?

A

Answer: The PR interval is constant, but the P wave is often not followed by a QRS complex.

252
Q

Question: What is characteristic of third-degree (complete) heart block?

A

Answer: There is no association between the P waves and QRS complexes.

253
Q

Question: What is B-type natriuretic peptide (BNP) and where is it produced?

A

Answer: BNP is a hormone produced mainly by the left ventricular myocardium in response to strain.

254
Q

Question: What conditions can raise B-type natriuretic peptide (BNP) levels?

A

Answer: BNP levels can be raised in heart failure, myocardial ischaemia, valvular disease, and chronic kidney disease (due to reduced excretion).

255
Q

Question: What factors can reduce BNP levels?

A

Answer: Treatment with ACE inhibitors, angiotensin-2 receptor blockers, and diuretics can reduce BNP levels.

256
Q

Question: What are the effects of B-type natriuretic peptide (BNP)?

A

Vasodilation
Diuretic and natriuretic effects
Suppression of sympathetic tone and the renin-angiotensin-aldosterone system

257
Q

Question: What is a clinical use of B-type natriuretic peptide (BNP)?

A

Answer: BNP is used in diagnosing patients with acute dyspnoea. A BNP level < 100 pg/ml makes heart failure unlikely, but raised levels should prompt further investigation to confirm the diagnosis.

258
Q

Question: What are beta-blockers primarily used for?

A

Answer: Beta-blockers are mainly used in the management of cardiovascular disorders.

259
Q

Question: What are the indications for beta-blocker use?

A

Angina
Post-myocardial infarction
Heart failure (certain beta-blockers improve symptoms and mortality)
Arrhythmias (used for rate control in atrial fibrillation)
Hypertension (role has diminished in recent years)
Thyrotoxicosis
Migraine prophylaxis
Anxiety

260
Q

Question: What are the common side effects of beta-blockers?

A

Bronchospasm
Cold peripheries
Fatigue
Sleep disturbances (including nightmares)
Erectile dysfunction

261
Q

Question: What are the contraindications for using beta-blockers?

A

Uncontrolled heart failure
Asthma
Sick sinus syndrome
Concurrent use with verapamil (may precipitate severe bradycardia)

262
Q

Question: What is Brugada syndrome?

A

Answer: Brugada syndrome is an inherited cardiovascular disease that may present with sudden cardiac death. It is inherited in an autosomal dominant fashion and has an estimated prevalence of 1:5,000-10,000. It is more common in Asians.

263
Q

Question: What are the characteristic ECG changes in Brugada syndrome?

A

Convex ST segment elevation > 2mm in > 1 of V1-V3 followed by a negative T wave
Partial right bundle branch block

264
Q

Question: How can the ECG changes in Brugada syndrome be made more apparent?

A

Answer: The ECG changes may become more apparent following the administration of flecainide or ajmaline, which is the investigation of choice in suspected cases of Brugada syndrome.

265
Q

Question: What is the management for Brugada syndrome?

A

Answer: Implantable cardioverter-defibrillator (ICD).

266
Q

Question: With what is Buerger’s disease strongly associated?

A

Answer: Smoking.

267
Q

Question: What are the features of Buerger’s disease?

A

Extremity ischaemia
Intermittent claudication
Ischaemic ulcers
Superficial thrombophlebitis
Raynaud’s phenomenon

268
Q

Question: Which cardiac enzyme rises first after myocardial infarction?

A

Answer: Myoglobin.

269
Q

Question: Which cardiac enzyme is useful for detecting reinfarction and why?

A

Answer: CK-MB, because it returns to normal after 2-3 days, whereas troponin T remains elevated for up to 10 days.

270
Q

Question: What cardiac markers have largely superseded the use of various cardiac enzymes in diagnosing myocardial infarction?

A

Answer: Troponin T and Troponin I.

271
Q

Question: What are the key points about Hypertrophic Obstructive Cardiomyopathy?

A

Leading cause of sudden cardiac death in young athletes
Usually due to a mutation in the gene encoding β-myosin heavy chain protein
Common cause of sudden death
Echo findings include mitral regurgitation (MR), systolic anterior motion (SAM) of the anterior mitral valve, and asymmetric septal hypertrophy

272
Q

Question: What are the key points about Arrhythmogenic Right Ventricular Dysplasia (ARVD)?

A

Right ventricular myocardium is replaced by fatty and fibrofatty tissue
Around 50% of patients have a mutation in genes encoding components of desmosome
ECG abnormalities in V1-3, typically T wave inversion. An epsilon wave is found in about 50% of those with ARVD, described as a terminal notch in the QRS complex

273
Q

Question: What are the classic causes of Dilated Cardiomyopathy?

A

Alcohol
Coxsackie B virus
Wet beriberi
Doxorubicin

274
Q

Question: What are the classic causes of Restrictive Cardiomyopathy?

A

Amyloidosis
Post-radiotherapy
Loeffler’s endocarditis

275
Q

Question: What is Peripartum Cardiomyopathy and when does it typically develop?

A

Answer: Peripartum cardiomyopathy typically develops between the last month of pregnancy and 5 months post-partum. It is more common in older women, those with greater parity, and multiple gestations.

276
Q

Question: What is Takotsubo Cardiomyopathy and its typical presentation?

A

Also known as “stress-induced cardiomyopathy”
Often occurs after a stressful event, such as finding out a family member has died
Patients develop chest pain and features of heart failure
Characterized by transient, apical ballooning of the myocardium
Treatment is supportive

277
Q

Question: What are the characteristic exam features of a Myocardial Infarction?

A

Heavy, central chest pain that may radiate to the neck and left arm
Nausea, sweating
Elderly patients and diabetics may experience no pain
Risk factors for cardiovascular disease

278
Q

Question: What are the characteristic exam features of a Pneumothorax?

A

History of asthma, Marfan’s syndrome, etc.
Sudden dyspnoea and pleuritic chest pain

279
Q

Question: What are the characteristic exam features of a Pulmonary Embolism?

A

Sudden dyspnoea and pleuritic chest pain
Calf pain/swelling
Current combined pill user, malignancy

280
Q

Question: What are the characteristic exam features of Pericarditis?

A

Sharp pain relieved by sitting forwards
May be pleuritic in nature

281
Q

Question: What are the characteristic exam features of a Dissecting Aortic Aneurysm?

A

‘Tearing’ chest pain radiating through to the back
Unequal upper limb blood pressure

282
Q

Question: What are the characteristic exam features of Gastro-oesophageal Reflux Disease (GERD)?

A

Burning retrosternal pain
Other possible symptoms include regurgitation and dysphagia

283
Q

Question: What are the characteristic exam features of Musculoskeletal Chest Pain?

A

Pain often worse on movement or palpation
May be precipitated by trauma or coughing

284
Q

Question: What are the characteristic exam features of Shingles?

A

Answer: Pain often precedes the rash

285
Q

Question: What is Aortic Dissection, and how is it diagnosed and treated?

A

Occurs when blood tracks into the medial layer of the aorta, creating a false lumen
Presents with tearing intrascapular pain
Most common in Afro-Caribbean males aged 50-70
Diagnosis suggested by widened mediastinum on chest X-ray and confirmed by CT angiography
Type A lesions (proximal) treated surgically, Type B lesions (distal) managed non-operatively

286
Q

Question: What are the typical presenting features and diagnostic methods for a Pulmonary Embolism?

A

Sudden onset of chest pain, haemoptysis, hypoxia, and small pleural effusions
Underlying deep vein thrombosis
ECG findings: S waves in lead I, Q waves in lead III, and inverted T waves in lead III
Diagnosed by CT pulmonary angiography
Treatment with anticoagulation, possible thrombolysis in severe cases

287
Q

Question: What are the typical presenting features and diagnostic methods for a Myocardial Infarction?

A

Sudden onset of central, crushing chest pain radiating to the neck and left arm
Atypical presentations in the elderly and diabetics
Diagnosed by dynamic ECG changes and cardiac enzyme changes
Treatment with oral antiplatelet agents, primary coronary angioplasty, and/or thrombolysis

288
Q

Question: What are the presenting features and treatment for a Perforated Peptic Ulcer?

A

Sudden onset of epigastric abdominal pain, followed by generalized abdominal pain
Erect chest X-ray may show free intra-abdominal air
Treatment usually with laparotomy, small defects excised and overlaid with an omental patch, larger defects managed with partial gastrectomy

289
Q

Question: What is Boerhaave’s Syndrome, and how is it diagnosed and treated?

A

Spontaneous rupture of the oesophagus due to severe vomiting
Presents with sudden onset of severe chest pain
Severe sepsis secondary to mediastinitis
Diagnosed by CT contrast swallow
Treatment with thoracotomy and lavage; primary repair if < 12 hours, T-tube for controlled fistula if > 12 hours

290
Q

Question: What role do loop diuretics play in heart failure management according to the NICE guidelines?

A

Answer: Loop diuretics, such as furosemide, are important for managing fluid overload but have not demonstrated a long-term reduction in mortality.

291
Q

Question: What is the first-line treatment for all patients with heart failure?

A

Answer: The first-line treatment is both an ACE inhibitor and a beta-blocker. Generally, one drug should be started at a time, based on clinical judgement.

292
Q

Question: Which beta-blockers are licensed to treat heart failure in the UK?

A

Answer: Bisoprolol, carvedilol, and nebivolol are the beta-blockers licensed to treat heart failure in the UK.

293
Q

Question: Do ACE inhibitors and beta-blockers affect mortality in heart failure with preserved ejection fraction?

A

Answer: No, ACE inhibitors and beta-blockers have no effect on mortality in heart failure with preserved ejection fraction.

294
Q

Question: What is the standard second-line treatment for heart failure according to NICE guidelines?

A

Answer: The standard second-line treatment is an aldosterone antagonist (mineralocorticoid receptor antagonist), such as spironolactone or eplerenone.

295
Q

Question: What should be monitored when a patient is on both ACE inhibitors and aldosterone antagonists?

A

Answer: Potassium levels should be monitored due to the risk of hyperkalaemia.

296
Q

Question: What role do SGLT-2 inhibitors play in heart failure management?

A

Answer: SGLT-2 inhibitors, such as canagliflozin, dapagliflozin, and empagliflozin, reduce glucose reabsorption and increase urinary glucose excretion. They have been shown to reduce hospitalisation and cardiovascular death in heart failure with reduced ejection fraction.

297
Q

Question: When should third-line treatment for heart failure be initiated and by whom?

A

Answer: Third-line treatment should be initiated by a specialist.

298
Q

Question: What are the criteria for using ivabradine in heart failure?

A

Answer: Ivabradine is indicated if the patient is in sinus rhythm with a heart rate > 75/min and has a left ventricular ejection fraction < 35%.

299
Q

Question: What is the role of digoxin in heart failure management?

A

Answer: Digoxin has not been proven to reduce mortality in heart failure but may improve symptoms due to its inotropic properties. It is strongly indicated if there is coexistent atrial fibrillation.

300
Q

Question: What are the indications for cardiac resynchronisation therapy in heart failure?

A

Answer: Indications include a widened QRS complex on ECG, such as left bundle branch block.

301
Q

Question: What vaccines should be offered to patients with heart failure?

A

Answer: Patients should be offered an annual influenza vaccine and a one-off pneumococcal vaccine. Adults with asplenia, splenic dysfunction, or chronic kidney disease need a booster every 5 years.

302
Q

Question: What is the New York Heart Association (NYHA) classification used for?

A

Answer: The NYHA classification is used to classify the severity of heart failure.

303
Q

Question: What are the characteristics of NYHA Class I heart failure?

A

No symptoms
No limitation: ordinary physical exercise does not cause undue fatigue, dyspnoea, or palpitations

304
Q

Question: What are the characteristics of NYHA Class II heart failure?

A

Mild symptoms
Slight limitation of physical activity: comfortable at rest but ordinary activity results in fatigue, palpitations, or dyspnoea

305
Q

Question: What are the characteristics of NYHA Class III heart failure?

A

Moderate symptoms
Marked limitation of physical activity: comfortable at rest but less than ordinary activity results in symptoms

306
Q

Question: What are the characteristics of NYHA Class IV heart failure?

A

Severe symptoms
Unable to carry out any physical activity without discomfort: symptoms of heart failure are present even at rest with increased discomfort with any physical activity

307
Q

Question: What is the most common form of cardiomyopathy?

A

Answer: Dilated cardiomyopathy (DCM), accounting for 90% of cases.

308
Q

Question: What is the most common cause of dilated cardiomyopathy?

A

Answer: Idiopathic.

309
Q

Question: Name some infectious causes of dilated cardiomyopathy.

A

Answer: Myocarditis (e.g., Coxsackie B, HIV, diphtheria, Chagas disease).

310
Q

Question: What are some non-infectious causes of dilated cardiomyopathy?

A

Answer: Ischaemic heart disease, peripartum, hypertension, iatrogenic (e.g., doxorubicin), substance abuse (e.g., alcohol, cocaine), inherited conditions (e.g., Duchenne muscular dystrophy), infiltrative diseases (e.g., haemochromatosis, sarcoidosis), nutritional deficiencies (e.g., wet beriberi).

311
Q

Question: What is the inheritance pattern for most genetic predispositions to dilated cardiomyopathy?

A

Answer: The majority of defects are inherited in an autosomal dominant fashion, although other patterns of inheritance are seen.

312
Q

Question: What is the pathophysiology of dilated cardiomyopathy?

A

Answer: Dilated heart leading to predominantly systolic dysfunction. All four chambers are dilated, but the left ventricle is more so than the right ventricle. Eccentric hypertrophy (sarcomeres added in series) is seen.

313
Q

Question: What are the classic clinical features of dilated cardiomyopathy?

A

Answer: Classic findings of heart failure, systolic murmur (due to stretching of the valves resulting in mitral and tricuspid regurgitation), S3 heart sound, ‘balloon’ appearance of the heart on chest x-ray.

314
Q

Question: What is the ECG criterion for diagnosing left ventricular hypertrophy (LVH)?

A

Answer: The sum of the S wave in V1 and the R wave in V5 or V6 exceeds 40 mm.

315
Q

Question: What is the ECG criterion for diagnosing right ventricular hypertrophy (RVH)?

A

Answer: The criterion for right ventricular hypertrophy is not explicitly given in the prompt. However, RVH can often be identified by a right axis deviation and tall R waves in the right precordial leads (V1 and V2).

316
Q

Question: What are the ECG features of left atrial enlargement (LAE)?

A

Bifid P wave in lead II with a duration > 120 ms.
In V1, the P wave has a negative terminal portion.

317
Q

Question: What are the ECG features of right atrial enlargement (RAE)?

A

Tall P waves in both lead II and V1 which exceed 0.25 mV.

318
Q

Question: What are the causes of left axis deviation (LAD)?

A

Left anterior hemiblock
Left bundle branch block
Inferior myocardial infarction
Wolff-Parkinson-White syndrome with a right-sided accessory pathway
Hyperkalaemia
Congenital conditions such as ostium primum ASD and tricuspid atresia
Minor LAD in obese people

319
Q

Question: What are the causes of right axis deviation (RAD)?

A

Right ventricular hypertrophy
Left posterior hemiblock
Lateral myocardial infarction
Chronic lung disease leading to cor pulmonale
Pulmonary embolism
Ostium secundum ASD
Wolff-Parkinson-White syndrome with a left-sided accessory pathway
Normal in infants under 1 year old
Minor RAD in tall people

320
Q

Question: What are the ECG features of digoxin toxicity?

A

Down-sloping ST depression (referred to as ‘reverse tick’ or ‘scooped out’)
Flattened or inverted T waves
Shortened QT interval
Arrhythmias such as AV block and bradycardia

321
Q

Question: What are the typical ECG features and common causes of left bundle branch block (LBBB)?

A

ECG Features:

WiLLiaM Pattern:
‘W’ shape in lead V1
‘M’ shape in lead V6
Wide QRS complexes (>120 ms)
Causes:

Myocardial infarction:
Diagnosing MI in patients with existing LBBB is challenging.
The Sgarbossa criteria can help diagnose MI in the presence of LBBB.
Hypertension
Aortic stenosis
Cardiomyopathy
Rare causes:
Idiopathic fibrosis
Digoxin toxicity
Hyperkalaemia
Note: New LBBB is always considered pathological and warrants further investigation.

322
Q

Question: What ECG changes are considered normal variants in athletes?

A

ECG Changes Considered Normal Variants in Athletes:

Sinus Bradycardia
A slower than normal heart rate (<60 bpm) due to high vagal tone.
Junctional Rhythm
Rhythm originating from the atrioventricular (AV) junction, often seen during rest or sleep.
First-Degree Heart Block
Prolonged PR interval (>200 ms) but with each P wave followed by a QRS complex.
Mobitz Type 1 (Wenckebach Phenomenon)
Progressive prolongation of the PR interval until a P wave is not followed by a QRS complex (dropped beat).

323
Q

Question: What are the causes of a prolonged PR interval and in which condition is a short PR interval seen?

A

Causes of a Prolonged PR Interval:

Idiopathic
Ischaemic heart disease
Digoxin toxicity
Hypokalaemia (more common association)
Rheumatic fever
Aortic root pathology (e.g., abscess secondary to endocarditis)
Lyme disease
Sarcoidosis
Myotonic dystrophy
Athletes (as a normal variant)
Note: Hyperkalaemia can rarely cause a prolonged PR interval, but it is a much less common association compared to hypokalaemia.

Condition Associated with a Short PR Interval:

Wolff-Parkinson-White syndrome

324
Q

Question: What are the common causes of right bundle branch block (RBBB) and how can you differentiate it from left bundle branch block (LBBB) on an ECG?

A

Differentiating RBBB from LBBB:

Mnemonic: WiLLiaM MaRRoW
LBBB: ‘W’ in V1 and ‘M’ in V6
RBBB: ‘M’ in V1 and ‘W’ in V6
Causes of Right Bundle Branch Block (RBBB):

Normal variant (more common with increasing age)
Right ventricular hypertrophy
Chronically increased right ventricular pressure (e.g., cor pulmonale)
Pulmonary embolism
Myocardial infarction
Atrial septal defect (ostium secundum)
Cardiomyopathy or myocarditis

325
Q

Question: What is Eisenmenger’s syndrome?

A

Answer: Eisenmenger’s syndrome describes the reversal of a left-to-right shunt in a congenital heart defect due to pulmonary hypertension. This occurs when an uncorrected left-to-right shunt leads to remodeling of the pulmonary microvasculature, eventually causing obstruction to pulmonary blood flow and pulmonary hypertension.

326
Q

Question: Which congenital heart defects are associated with Eisenmenger’s syndrome?

A

Ventricular septal defect (VSD)
Atrial septal defect (ASD)
Patent ductus arteriosus (PDA)

327
Q

Question: What are the clinical features of Eisenmenger’s syndrome?

A

Original murmur may disappear
Cyanosis
Clubbing
Right ventricular failure
Haemoptysis
Embolism

328
Q

Question: What is the management for Eisenmenger’s syndrome?

A

Answer: Heart-lung transplantation is required.

329
Q

Question: How does Eisenmenger’s syndrome develop from a congenital heart defect?

A

Answer: Eisenmenger’s syndrome develops when a left-to-right shunt caused by a congenital heart defect is left uncorrected. This leads to remodeling of the pulmonary microvasculature, increased pulmonary vascular resistance, and ultimately, pulmonary hypertension, reversing the shunt to right-to-left.

330
Q

Question: What happens to the original murmur in Eisenmenger’s syndrome?

A

Answer: The original murmur may disappear in Eisenmenger’s syndrome.

331
Q

Question: Why does cyanosis occur in Eisenmenger’s syndrome?

A

Answer: Cyanosis occurs in Eisenmenger’s syndrome due to the reversal of the shunt from left-to-right to right-to-left, leading to deoxygenated blood entering the systemic circulation.

332
Q

Question: What are the signs of right ventricular failure seen in Eisenmenger’s syndrome?

A

Answer: Signs of right ventricular failure in Eisenmenger’s syndrome include cyanosis, clubbing, and haemoptysis.

333
Q

Question: Why is heart-lung transplantation required for Eisenmenger’s syndrome?

A

Answer: Heart-lung transplantation is required for Eisenmenger’s syndrome because of the severe pulmonary hypertension and the irreversible damage to the pulmonary vasculature.

334
Q

Question: What is Acute Heart Failure (AHF)?

A

Answer: Acute Heart Failure (AHF) is a life-threatening emergency characterized by the sudden onset or worsening of heart failure symptoms, which can present with or without a history of pre-existing heart failure. AHF without a past history of heart failure is called de-novo AHF.

335
Q

Question: What is de-novo Acute Heart Failure?

A

Answer: De-novo Acute Heart Failure refers to AHF occurring without a past history of heart failure, often caused by increased cardiac filling pressures and myocardial dysfunction, usually as a result of ischemia, which reduces cardiac output and causes hypoperfusion and pulmonary edema.

336
Q

Question: What are common causes of de-novo Acute Heart Failure?

A

Answer: Common causes of de-novo AHF include:

Ischemia
Viral myopathy
Toxins
Valve dysfunction

337
Q

Question: What is decompensated Acute Heart Failure?

A

Answer: Decompensated Acute Heart Failure is a more common form of AHF that occurs in patients with a background history of heart failure. It often presents with signs of fluid congestion, weight gain, orthopnea, and breathlessness.

338
Q

Question: What are the most common precipitating causes of decompensated Acute Heart Failure?

A

Acute coronary syndrome
Hypertensive crisis
Acute arrhythmia
Valvular disease

339
Q

Question: How are patients with Acute Heart Failure categorized?

A

Answer: Patients with AHF are broadly characterized into one of four groups based on their presentation:

With or without hypoperfusion
With or without fluid congestion
This classification is clinically useful for determining the therapeutic approach.

340
Q

Question: What are the common symptoms and signs of Acute Heart Failure?

A

Symptoms:

Breathlessness
Reduced exercise tolerance
Edema
Fatigue
Signs:

Cyanosis
Tachycardia
Elevated jugular venous pressure
Displaced apex beat
Chest signs: bibasal crackles or wheeze
S3 heart sound

341
Q

Question: What percentage of patients with Acute Heart Failure have a normal or increased blood pressure?

A

Answer: Over 90% of patients with AHF have a normal or increased blood pressure.

342
Q

Question: What are the components of the diagnostic workup for Acute Heart Failure?

A

Blood tests: To identify underlying abnormalities such as anemia, abnormal electrolytes, or infection.
Chest X-ray: To detect pulmonary venous congestion, interstitial edema, and cardiomegaly.
Echocardiogram: Recommended for new-onset heart failure or suspected changes in cardiac function.
B-type natriuretic peptide (BNP): Raised levels (>100 mg/litre) indicate myocardial damage and support the diagnosis.

343
Q

Question: What are the chest X-ray findings in patients with Acute Heart Failure?

A

Answer: Chest X-ray findings in AHF include pulmonary venous congestion, interstitial edema, and cardiomegaly.

344
Q

Question: What is a common respiratory symptom of chronic heart failure?

A

Answer: Dyspnoea (shortness of breath).

345
Q

Question: What type of cough is associated with chronic heart failure?

A

Answer: A cough that may be worse at night and associated with pink/frothy sputum.

346
Q

Question: What term describes shortness of breath that occurs when lying flat in chronic heart failure patients?

A

Answer: Orthopnoea.

347
Q

Question: What is paroxysmal nocturnal dyspnoea?

A

Answer: It is a sudden onset of severe shortness of breath at night that awakens the patient from sleep.

348
Q

Question: What is ‘cardiac wheeze’?

A

Answer: A wheezing sound associated with chronic heart failure due to pulmonary congestion.

349
Q

Question: What is cardiac cachexia?

A

Answer: Weight loss seen in chronic heart failure patients, occurring in up to 15% of patients, and may be hidden by weight gained due to oedema.

350
Q

Question: What might be heard on chest examination in a patient with chronic heart failure?

A

Answer: Bibasal crackles.

351
Q

Question: What are the signs of right-sided heart failure?

A

Raised jugular venous pressure (JVP)
Ankle oedema
Hepatomegaly

352
Q

Question: What is the first-line treatment for all patients with acute heart failure?

A

Answer: IV loop diuretics (e.g. furosemide or bumetanide).

353
Q

Question: What is the recommended oxygen saturation target for patients with acute heart failure?

A

Answer: 94-98%, in line with British Thoracic Society guidelines.

354
Q

Question: When might nitrates be used in the management of acute heart failure?

A

Answer: Nitrates may be used if there is concomitant myocardial ischaemia, severe hypertension, or regurgitant aortic or mitral valve disease.

355
Q

Question: What is the major side effect/contraindication of nitrate use in acute heart failure?

A

Answer: Hypotension.

356
Q

Question: What treatment is recommended for patients with acute heart failure and respiratory failure?

A

Answer: Continuous positive airway pressure (CPAP).

357
Q

Question: What is a key consideration in the management of acute heart failure with hypotension or cardiogenic shock?

A

Answer: Some treatments for acute heart failure (e.g., loop diuretics and nitrates) may exacerbate hypotension.

358
Q

Question: Which inotropic agent might be used for patients with severe left ventricular dysfunction and potentially reversible cardiogenic shock?

A

Answer: Dobutamine.

359
Q

Question: Under what circumstances should beta-blockers be stopped in patients with acute heart failure?

A

Answer: Beta-blockers should only be stopped if the patient has a heart rate less than 50 beats per minute, second or third degree atrioventricular block, or shock.

360
Q

Question: How is heart failure defined?

A

Answer: Heart failure is defined as a clinical syndrome where the heart is unable to pump enough blood to meet the metabolic needs of the body, usually due to structural or functional heart disease.

361
Q

Question: What are the two main types of heart failure based on ejection fraction?

A

Heart failure with reduced ejection fraction (HF-rEF), typically defined as LVEF < 35-40%.
Heart failure with preserved ejection fraction (HF-pEF), where LVEF is normal or near-normal.

362
Q

Question: What is the typical cause of systolic dysfunction?

A

Answer: Systolic dysfunction is typically caused by conditions such as ischaemic heart disease, dilated cardiomyopathy, myocarditis, and arrhythmias.

363
Q

Question: What is the typical cause of diastolic dysfunction?

A

Answer: Diastolic dysfunction is typically caused by conditions such as hypertrophic obstructive cardiomyopathy, restrictive cardiomyopathy, cardiac tamponade, and constrictive pericarditis.

364
Q

Question: How is heart failure typically described in terms of time?

A

Answer: Heart failure is typically described as acute or chronic. Acute heart failure often refers to an acute exacerbation of chronic heart failure.

365
Q

Question: What are the most urgent symptoms of acute heart failure?

A

Answer: The most urgent symptoms of acute heart failure are often due to left ventricular failure, resulting in pulmonary oedema.

366
Q

Question: What are the common features of left ventricular failure?

A

Answer: Common features of left ventricular failure include pulmonary oedema, dyspnoea, orthopnoea, paroxysmal nocturnal dyspnoea, and bibasal fine crackles.

367
Q

Question: What are the common features of right ventricular failure?

A

Answer: Common features of right ventricular failure include peripheral oedema, ankle/sacral oedema, raised jugular venous pressure, hepatomegaly, weight gain due to fluid retention, and anorexia (‘cardiac cachexia’).

368
Q

Question: What is high-output heart failure?

A

Answer: High-output heart failure refers to a situation where a ‘normal’ heart is unable to pump enough blood to meet the metabolic needs of the body.

369
Q

Question: What are some causes of high-output heart failure?

A

Answer: Causes of high-output heart failure include anaemia, arteriovenous malformation, Paget’s disease, pregnancy, thyrotoxicosis, and thiamine deficiency (wet Beri-Beri).

370
Q

Question: What causes right-sided heart failure?

A

Answer: Right-sided heart failure is caused by increased right ventricular afterload (e.g. pulmonary hypertension) or increased right ventricular preload (e.g. tricuspid regurgitation).

371
Q

Question: What condition is associated with a short PR interval?

A

Answer: Wolff-Parkinson-White syndrome is associated with a short PR interval.

372
Q

Question: What causes the first heart sound (S1)?

A

Answer: The first heart sound (S1) is caused by the closure of the mitral and tricuspid valves.

373
Q

Question: When is the first heart sound (S1) soft?

A

Answer: The first heart sound (S1) is soft if there is a long PR interval or mitral regurgitation.

374
Q

Question: When is the first heart sound (S1) loud?

A

Mitral stenosis
Left-to-right shunts
Short PR interval, atrial premature beats
Hyperdynamic states

375
Q

Question: What causes the second heart sound (S2)?

A

Answer: The second heart sound (S2) is caused by the closure of the aortic and pulmonary valves.

376
Q

Question: When is the second heart sound (S2) soft?

A

Answer: The second heart sound (S2) is soft in aortic stenosis.

377
Q

Question: What is normal regarding the splitting of the second heart sound (S2)?

A

Answer: Splitting of the second heart sound (S2) during inspiration is normal.

378
Q

Question: What causes the third heart sound (S3)?

A

Answer: The third heart sound (S3) is caused by the diastolic filling of the ventricle.

379
Q

Question: In which conditions is the third heart sound (S3) heard?

A

Answer: The third heart sound (S3) is heard in left ventricular failure (e.g., dilated cardiomyopathy), constrictive pericarditis (called a pericardial knock), and mitral regurgitation.

380
Q

Question: When is the third heart sound (S3) considered normal?

A

Answer: The third heart sound (S3) is considered normal if the individual is under 30 years old (may persist in women up to 50 years old).

381
Q

Question: What causes the fourth heart sound (S4)?

A

Answer: The fourth heart sound (S4) is caused by atrial contraction against a stiff ventricle.

382
Q

Question: In which conditions can the fourth heart sound (S4) be heard?

A

Answer: The fourth heart sound (S4) may be heard in aortic stenosis, hypertrophic obstructive cardiomyopathy (HOCM), and hypertension.

383
Q

Question: How is the fourth heart sound (S4) related to the ECG?

A

Answer: The fourth heart sound (S4) coincides with the P wave on an ECG.

384
Q

Question: What unique physical finding is associated with S4 in hypertrophic obstructive cardiomyopathy (HOCM)?

A

Answer: In hypertrophic obstructive cardiomyopathy (HOCM), a double apical impulse may be felt as a result of a palpable S4.

385
Q

Answer: Causes of a loud second heart sound (S2) include:

A

Hypertension: systemic (loud A2) or pulmonary (loud P2)
Hyperdynamic states
Atrial septal defect without pulmonary hypertension

386
Q

Question: What are the causes of a widely split second heart sound (S2)?

A

Causes of a widely split second heart sound (S2) include:

Deep inspiration
Right bundle branch block (RBBB)
Pulmonary stenosis
Severe mitral regurgitation

387
Q

Question: What are the causes of a reversed (paradoxical) split second heart sound (S2), where P2 occurs before A2?

A

Causes of a reversed (paradoxical) split second heart sound (S2) include:

Left bundle branch block (LBBB)
Severe aortic stenosis
Right ventricular pacing
Wolff-Parkinson-White (WPW) syndrome type B (causes early P2)
Patent ductus arteriosus

388
Q

Question: How does NICE define hypertension?

A

NICE defines hypertension as:

A clinic reading persistently above ≥ 140/90 mmHg, or
A 24-hour blood pressure average reading ≥ 135/85 mmHg

389
Q

Question: What are some renal causes of secondary hypertension?

A

Glomerulonephritis
Chronic pyelonephritis
Adult polycystic kidney disease
Renal artery stenosis

390
Q

Question: What are some endocrine causes of secondary hypertension?

A

Primary hyperaldosteronism
Phaeochromocytoma
Cushing’s syndrome
Liddle’s syndrome
Congenital adrenal hyperplasia (11-beta hydroxylase deficiency)
Acromegaly

391
Q

Question: What are some other causes of secondary hypertension?

A

Glucocorticoids
NSAIDs
Pregnancy
Coarctation of the aorta
Combined oral contraceptive pill

392
Q

Question: What investigations are recommended for patients with newly diagnosed hypertension?

A

Fundoscopy: to check for hypertensive retinopathy
Urine dipstick: to check for renal disease
ECG: to check for left ventricular hypertrophy or ischaemic heart disease

393
Q

Question: What tests are typically performed following a hypertension diagnosis?

A

24-hour blood pressure monitoring
Urea and electrolytes
HbA1c (for diabetes mellitus)
Lipid profile (for hyperlipidaemia)
ECG
Urine dipstick

394
Q

Question: What are the common drugs used to treat hypertension and their mechanisms and side effects?

A

ACE inhibitors: Inhibit conversion of angiotensin I to angiotensin II. Common side effects include cough, angioedema, and hyperkalaemia. First-line treatment in younger patients (< 55 years old).
Calcium channel blockers: Block voltage-gated calcium channels, relaxing vascular smooth muscle. Common side effects include flushing, ankle swelling, and headache. First-line treatment in older patients (≥ 55 years old).
Thiazide diuretics: Inhibit sodium absorption at the beginning of the distal convoluted tubule. Common side effects include hyponatraemia, hypokalaemia, and dehydration.
Angiotensin II receptor blockers (A2RB): Block effects of angiotensin II at the AT1 receptor. Common side effects include hyperkalaemia. Used when patients do not tolerate ACE inhibitors due to cough.

395
Q

Question: According to the 2008 NICE guidelines, which procedures do NOT require antibiotic prophylaxis for infective endocarditis?

A

Dental procedures
Upper and lower gastrointestinal tract procedures
Genitourinary tract procedures, including urological, gynecological, and obstetric procedures and childbirth
Upper and lower respiratory tract procedures, including ear, nose, and throat procedures and bronchoscopy

396
Q

Question: What does the jugular venous pulse (JVP) provide information about?

A

Answer: The jugular venous pulse provides information about right atrial pressure and can offer clues to underlying valvular disease.

397
Q

Question: What is Kussmaul’s sign, and in what condition is it observed?

A

Answer: Kussmaul’s sign describes a paradoxical rise in JVP during inspiration, seen in constrictive pericarditis.

398
Q

Question: What are cannon ‘a’ waves, and when are they seen?

A

Answer: Cannon ‘a’ waves are caused by atrial contractions against a closed tricuspid valve. They are seen in complete heart block, ventricular tachycardia/ectopics, nodal rhythm, and single-chamber ventricular pacing.

399
Q

Question: What does the ‘v’ wave in the JVP represent, and when are giant ‘v’ waves observed?

A

Answer: The ‘v’ wave represents passive filling of blood into the atrium against a closed tricuspid valve. Giant ‘v’ waves are observed in tricuspid regurgitation.

400
Q

Question: What is mitral regurgitation (MR)?

A

Answer: Mitral regurgitation (MR) occurs when blood leaks back through the mitral valve during systole, leading to reduced efficiency of the heart as less blood is pumped with each contraction.

401
Q

Question: What is the second most common valve disease after aortic stenosis?

A

Answer: Mitral regurgitation (MR) is the second most common valve disease after aortic stenosis.

402
Q

Question: What are the risk factors for developing mitral regurgitation?

A

Female sex
Lower body mass
Age
Renal dysfunction
Prior myocardial infarction (MI)
Prior mitral stenosis or valve prolapse
Collagen disorders (e.g., Marfan’s Syndrome, Ehlers-Danlos syndrome)

403
Q

Question: What are some common causes of mitral regurgitation?

A

Coronary artery disease (CAD) or post-MI
Mitral valve prolapse
Infective endocarditis
Rheumatic fever (less common in developed countries)
Congenital causes

404
Q

Question: Are most patients with mitral regurgitation symptomatic or asymptomatic?

A

Answer: Most patients with MR are asymptomatic, especially those with mild to moderate MR. Symptoms, if present, are often due to left ventricular failure, arrhythmias, or pulmonary hypertension.

405
Q

Question: What symptoms may patients with severe mitral regurgitation experience?

A

Answer: Patients with severe MR may experience fatigue, shortness of breath, and edema.

406
Q

Question: What does the murmur of mitral regurgitation sound like, and where is it heard?

A

Answer: The murmur of MR is typically a pansystolic murmur described as “blowing” and is best heard at the apex, radiating into the axilla.

407
Q

Question: What are the findings on auscultation for severe mitral regurgitation?

A

Answer: In severe MR, S1 may be quiet due to incomplete closure of the valve, and S2 may be widely split.

408
Q

Question: What are the treatment options for acute mitral regurgitation?

A

Nitrates, diuretics, positive inotropes, and intra-aortic balloon pump to increase cardiac output.

409
Q

Question: What are the key investigations for mitral regurgitation?

A

ECG: May show a broad P wave (atrial enlargement)
Chest X-ray: May show cardiomegaly with an enlarged left atrium and ventricle
Echocardiography: Crucial for diagnosis and assessing the severity of MR

410
Q

Question: What medications are considered for chronic mitral regurgitation in heart failure?

A

Answer: In heart failure, ACE inhibitors, beta-blockers, and spironolactone may be considered for chronic MR.

411
Q

Question: What is the treatment approach for acute, severe mitral regurgitation?

A

Answer: In acute, severe MR, surgery is indicated. Valve repair is preferred over replacement due to better outcomes. If repair is not possible, valve replacement with an artificial or pig valve is considered.

412
Q

Question: What is the most common cause of death following a myocardial infarction (MI)?

A

Answer: The most common cause of death following MI is cardiac arrest, usually due to ventricular fibrillation.

413
Q

Question: What is cardiogenic shock, and what causes it after MI?

A

Answer: Cardiogenic shock occurs when a large portion of the ventricular myocardium is damaged, resulting in decreased ejection fraction. It is often difficult to treat and may require inotropic support or an intra-aortic balloon pump.

414
Q

Question: What is the role of medications in managing chronic heart failure following MI?

A

Answer: In chronic heart failure following MI, loop diuretics (e.g., furosemide) are used to reduce fluid overload, while ACE inhibitors and beta-blockers improve long-term prognosis.

415
Q

Question: What arrhythmias are common after a myocardial infarction?

A

Common arrhythmias following MI include:

Ventricular fibrillation (most common cause of death)
Ventricular tachycardia
Bradyarrhythmias such as atrioventricular block (especially after inferior MI)

416
Q

Question: What is the typical presentation of pericarditis following a myocardial infarction?

A

Pericarditis within the first 48 hours of a transmural MI is common, presenting with:

Chest pain (worse when lying flat)
Pericardial rub on auscultation
Pericardial effusion (detected on echocardiogram)

417
Q

Question: What is Dressler’s syndrome, and when does it typically occur after an MI?

A

Dressler’s syndrome occurs 2-6 weeks after MI and is thought to be an autoimmune reaction. It presents with:

Fever
Pleuritic pain
Pericardial effusion
Raised ESR It is treated with NSAIDs.

418
Q

Question: What is a left ventricular aneurysm and how is it related to MI?

A

Answer: A left ventricular aneurysm occurs when ischemic damage weakens the myocardium, leading to aneurysm formation. It is typically associated with persistent ST elevation and left ventricular failure. Thrombus may form in the aneurysm, increasing the risk of stroke, so anticoagulation is often required.

419
Q

Question: What is left ventricular free wall rupture, and how is it managed?

A

Answer: Left ventricular free wall rupture occurs in about 3% of MI patients, typically 1-2 weeks after MI. It presents with acute heart failure and cardiac tamponade (raised JVP, pulsus paradoxus, diminished heart sounds). Urgent pericardiocentesis and thoracotomy are required.

420
Q

Question: What is a ventricular septal defect following MI, and how is it diagnosed and treated?

A

Answer: A ventricular septal defect (VSD) can occur within the first week after MI, causing acute heart failure and a pan-systolic murmur. It is diagnosed by echocardiography and requires urgent surgical correction.

421
Q

Question: What causes acute mitral regurgitation after MI, and how is it managed?

A

Answer: Acute mitral regurgitation following MI is more common with infero-posterior infarctions and may be due to ischemia or rupture of the papillary muscle. It presents with acute hypotension and pulmonary edema, and requires vasodilator therapy and often emergency surgical repair.

422
Q

Question: What is myocarditis?

A

Answer: Myocarditis is the inflammation of the myocardium, which can have a variety of underlying causes. It should be particularly considered in younger patients who present with chest pain.

423
Q

Question: What are the common causes of myocarditis?

A

Common causes of myocarditis include:

Viral: Coxsackie B, HIV
Bacterial: Diphtheria, Clostridia
Spirochaetes: Lyme disease
Protozoa: Chagas’ disease, Toxoplasmosis
Autoimmune diseases
Drugs: Doxorubicin

424
Q

Question: What are the typical symptoms of myocarditis?

A

The typical presentation includes:

Young patient with acute history
Chest pain
Dyspnoea
Arrhythmias

425
Q

Question: What blood tests are useful in diagnosing myocarditis?

A

Blood tests commonly show:

Elevated inflammatory markers (99% of cases)
Elevated cardiac enzymes
Elevated BNP

426
Q

Question: What are the ECG findings in myocarditis?

A

ECG findings in myocarditis include:

Tachycardia
Arrhythmias
ST/T wave changes, such as ST-segment elevation and T wave inversion

427
Q

Question: How is myocarditis managed?

A

Management of myocarditis includes:

Treating the underlying cause (e.g., antibiotics for bacterial infections)
Supportive care for heart failure or arrhythmias

428
Q

Question: What are the potential complications of myocarditis?

A

Complications of myocarditis include:

Heart failure
Arrhythmias, which may lead to sudden death
Dilated cardiomyopathy, usually a late complication

429
Q

Question: What is orthostatic hypotension?

A

Answer: Orthostatic hypotension is a condition characterized by a significant drop in blood pressure (usually >20/10 mm Hg) within three minutes of standing, leading to symptoms such as presyncope or syncope.

430
Q

Question: Who is more at risk for orthostatic hypotension?

A

Orthostatic hypotension is more common in:

Older individuals
Patients with neurodegenerative diseases (e.g., Parkinson’s disease)
Patients with diabetes or hypertension

431
Q

Question: What are some iatrogenic causes of orthostatic hypotension?

A

Iatrogenic causes include:

Alpha-blockers (e.g., used for benign prostatic hyperplasia)

432
Q

Question: What are the common features of orthostatic hypotension?

A

Features of orthostatic hypotension include:

A drop in blood pressure (>20/10 mm Hg) within three minutes of standing
Presyncope or syncope

433
Q

Question: What is the management of orthostatic hypotension?

A

Treatment options for orthostatic hypotension include:

Midodrine (a vasopressor)
Fludrocortisone (a corticosteroid that increases blood volume)

434
Q

Question: What defines postural hypotension?

A

Answer: Postural hypotension is defined as a fall in systolic blood pressure > 20 mmHg on standing.

435
Q

Question: What are the causes of postural hypotension?

A

Hypovolaemia (e.g., dehydration, blood loss)
Autonomic dysfunction (e.g., diabetes, Parkinson’s disease)
Drugs:
Diuretics
Antihypertensives
L-dopa (used in Parkinson’s disease)
Phenothiazines (antipsychotics)
Antidepressants
Sedatives
Alcohol consumption

436
Q

Question: What is pulsus paradoxus and what conditions are associated with it?

A

Pulsus paradoxus is a greater than normal (>10 mmHg) fall in systolic blood pressure during inspiration, causing a faint or absent pulse during inspiration. It is commonly seen in:

Severe asthma
Cardiac tamponade

437
Q

Question: What is a slow-rising/plateau pulse and which condition is it associated with?

A

Answer: A slow-rising/plateau pulse is characterized by a gradual increase in the pulse, often associated with aortic stenosis.

438
Q

Question: What is a collapsing pulse and what conditions are associated with it?

A

Answer: A collapsing pulse is a pulse that rises quickly and falls abruptly. It is associated with:

Aortic regurgitation
Patent ductus arteriosus
Hyperkinetic states (e.g., anaemia, thyrotoxicosis, fever, exercise, pregnancy)

439
Q

Question: What is pulsus alternans and what condition is it associated with?

A

Answer: Pulsus alternans is characterized by a regular alternation of the force of the arterial pulse, and it is commonly seen in severe left ventricular failure (LVF).

440
Q

Question: What is a bisferiens pulse and what condition is it associated with?

A

Answer: A bisferiens pulse is a ‘double pulse’ with two systolic peaks. It is commonly associated with mixed aortic valve disease.

441
Q

Question: What is a jerky pulse and what condition is it associated with?

A

Answer: A jerky pulse is a quick, abrupt rise and fall in pulse force, and it is typically associated with hypertrophic obstructive cardiomyopathy (HOCM).

442
Q

Question: What is the general definition of supraventricular tachycardia (SVT) and what are its most common types?

A

Answer: SVT refers to any tachycardia that originates above the ventricles. It is often used to describe paroxysmal SVT, characterized by sudden onset of narrow complex tachycardia. Common types include:

Atrioventricular nodal re-entry tachycardia (AVNRT)
Atrioventricular re-entry tachycardia (AVRT)
Junctional tachycardias

443
Q

Question: What is the initial acute management of supraventricular tachycardia (SVT)?

A

Vagal manoeuvres:
Valsalva manoeuvre (e.g., blowing into an empty plastic syringe)
Carotid sinus massage
Intravenous adenosine:
Rapid IV bolus: 6mg
If unsuccessful, give 12mg, then 18mg if needed
Contraindicated in asthmatics, in which case verapamil is preferred
Electrical cardioversion (if the above methods fail)

444
Q

Question: What are the preventative treatments for supraventricular tachycardia (SVT)?

A

Beta-blockers
Radio-frequency ablation

445
Q

Question: What is the definition of syncope?

A

Answer: Syncope is a transient loss of consciousness caused by global cerebral hypoperfusion, with rapid onset, short duration, and spontaneous complete recovery. It excludes other causes of collapse, such as epilepsy.

446
Q

Question: What are the main types of syncope according to the European Society of Cardiology guidelines (2009)?

A

Reflex syncope (neurally mediated):

Vasovagal: Triggered by emotion, pain, or stress
Situational: Triggered by specific actions like cough, micturition, or gastrointestinal issues
Carotid sinus syncope

Orthostatic syncope:

Primary autonomic failure: e.g., Parkinson’s, Lewy body dementia
Secondary autonomic failure: e.g., diabetic neuropathy, amyloidosis, uraemia
Drug-induced: e.g., diuretics, alcohol, vasodilators
Volume depletion: e.g., haemorrhage, diarrhoea

Cardiac syncope:

Arrhythmias: Bradycardias (sinus node dysfunction, AV conduction disorders) or tachycardias (supraventricular, ventricular)
Structural causes: e.g., valvular disease, myocardial infarction, hypertrophic obstructive cardiomyopathy
Others: e.g., pulmonary embolism

447
Q

Question: Which type of syncope is the most common across all age groups?

A

Answer: Reflex syncope (neurally mediated) is the most common cause of syncope in all age groups, although orthostatic and cardiac causes become more common in older patients.

448
Q

Question: What is involved in the evaluation of a patient with syncope?

A

Cardiovascular examination
Postural blood pressure readings: A symptomatic fall in systolic BP > 20 mmHg, diastolic BP > 10 mmHg, or a decrease in systolic BP < 90 mmHg is diagnostic of orthostatic syncope.
ECG for all patients
Other tests depending on clinical features
Patients with typical features, no postural drop, and a normal ECG do not require further investigations

449
Q

Question: What is Torsades de Pointes?

A

Answer: Torsades de Pointes is a form of polymorphic ventricular tachycardia associated with a long QT interval. It may deteriorate into ventricular fibrillation, leading to sudden death.

450
Q

Question: What are the causes of a long QT interval that can lead to Torsades de Pointes?

A

Answer: Causes of long QT interval include:

Congenital:
Jervell-Lange-Nielsen syndrome
Romano-Ward syndrome
Antiarrhythmics: e.g., amiodarone, sotalol, class 1a antiarrhythmic drugs
Medications:
Tricyclic antidepressants
Antipsychotics
Chloroquine
Terfenadine
Erythromycin
Electrolyte disturbances:
Hypocalcaemia
Hypokalaemia
Hypomagnesaemia
Other causes:
Myocarditis
Hypothermia
Subarachnoid haemorrhage

451
Q

Question: What is the first-line treatment for Torsades de Pointes?

A

Answer: The first-line treatment for Torsades de Pointes is IV magnesium sulphate.

452
Q

Question: What are the signs of Tricuspid Regurgitation?

A

Signs of Tricuspid Regurgitation include:

Pan-systolic murmur
Prominent/giant V waves in the JVP
Pulsatile hepatomegaly
Left parasternal heave

453
Q

Question: What are the causes of Tricuspid Regurgitation?

A

Causes of Tricuspid Regurgitation include:

Right ventricular infarction
Pulmonary hypertension (e.g., COPD)
Rheumatic heart disease
Infective endocarditis (especially in intravenous drug users)
Ebstein’s anomaly
Carcinoid syndrome

454
Q

Question: What is Ventricular Tachycardia (VT), and what are its types?

A

Answer: Ventricular Tachycardia (VT) is a broad-complex tachycardia originating from a ventricular ectopic focus. It can lead to ventricular fibrillation and requires urgent treatment.
The two main types of VT are:

Monomorphic VT: Most commonly caused by myocardial infarction.
Polymorphic VT: Includes torsades de pointes, which is caused by a prolonged QT interval.

455
Q

Question: What are the causes of a prolonged QT interval that can precipitate polymorphic VT (including torsades de pointes)?

A

Answer: Causes of a prolonged QT interval include:

Congenital:
Jervell-Lange-Nielsen syndrome (includes deafness, due to abnormal potassium channels)
Romano-Ward syndrome (no deafness)
Drugs:
Amiodarone, sotalol, class 1a antiarrhythmic drugs
Tricyclic antidepressants, fluoxetine
Chloroquine, terfenadine, erythromycin
Other:
Electrolyte imbalances (e.g., hypocalcaemia, hypokalaemia, hypomagnesaemia)
Acute myocardial infarction
Myocarditis
Hypothermia
Subarachnoid haemorrhage

456
Q

Question: What is the management for Ventricular Tachycardia (VT)?

A

Answer:

If the patient has adverse signs (e.g., systolic BP < 90 mmHg, chest pain, heart failure), immediate cardioversion is indicated.
In the absence of adverse signs, antiarrhythmics can be used. If these fail, synchronised electrical cardioversion may be needed.
Drug Therapy:

Amiodarone: Ideally administered through a central line.
Lidocaine: Use with caution in severe left ventricular impairment.
Procainamide: Another option.
Important: Verapamil should NOT be used in VT.

If drug therapy fails:
Electrophysiological study (EPS).
Implantable cardioverter-defibrillator (ICD): Particularly indicated in patients with significantly impaired LV function.

457
Q

Question: What is Wolff-Parkinson-White (WPW) syndrome, and what causes it?

A

Answer: WPW syndrome is caused by a congenital accessory conducting pathway between the atria and ventricles, leading to atrioventricular re-entry tachycardia (AVRT). This pathway bypasses the normal AV node conduction, which allows rapid conduction and can cause atrial fibrillation (AF), which may degenerate rapidly into ventricular fibrillation (VF).

458
Q

Question: What are the key ECG features of Wolff-Parkinson-White (WPW) syndrome?

A

Short PR interval
Wide QRS complexes with a slurred upstroke, called the ‘delta wave’
Left axis deviation if the accessory pathway is right-sided
Right axis deviation if the accessory pathway is left-sided

459
Q

Question: How do you differentiate between type A and type B WPW?

A

Type A (left-sided pathway): Dominant R wave in V1.
Type B (right-sided pathway): No dominant R wave in V1.

460
Q

Question: What are the common associations with Wolff-Parkinson-White (WPW) syndrome?

A

Hypertrophic obstructive cardiomyopathy (HOCM)
Mitral valve prolapse
Ebstein’s anomaly
Thyrotoxicosis
Secundum atrial septal defect (ASD)

461
Q

Question: What is the management for Wolff-Parkinson-White (WPW) syndrome?

A

Definitive treatment: Radiofrequency ablation of the accessory pathway.
Medical therapy:
Sotalol, amiodarone, flecainide.
Caution: Sotalol should be avoided in patients with coexistent atrial fibrillation (AF), as it may prolong the refractory period at the AV node, increasing the rate of transmission through the accessory pathway, leading to potential ventricular fibrillation (VF).

462
Q

When cant you take statins

A

pregnancy
macrolides

463
Q

if doing fibrinolysis for STEMI, what do you give

A

alteplase and fondaparinux

464
Q

What scoring system is used to see if a PE patient can be managed as an outpatient

A

Pulmonary Embolism Severity Index (PESI) score

465
Q

What drug should you avoid in VT

A

verapamil

466
Q

Q: What is the management for major bleeding (e.g., variceal hemorrhage, intracranial hemorrhage) in a patient on warfarin?

A

Stop warfarin.
Give intravenous vitamin K 5mg.
Administer prothrombin complex concentrate or fresh frozen plasma (FFP) if prothrombin complex concentrate is not available.

467
Q

Q: What should be done if the INR is greater than 8.0 with minor bleeding in a patient on warfarin?

A

Stop warfarin.
Give intravenous vitamin K 1-3mg.
Repeat the dose of vitamin K if the INR is still too high after 24 hours.
Restart warfarin when the INR is less than 5.0.

468
Q

Q: What is the recommended action if the INR is greater than 8.0 without bleeding in a patient on warfarin?

A

Stop warfarin.
Give vitamin K 1-5mg by mouth (using the intravenous preparation orally).
Repeat the dose of vitamin K if the INR is still too high after 24 hours.
Restart warfarin when the INR is less than 5.0.

469
Q

Q: How should minor bleeding be managed if the INR is between 5.0 and 8.0 in a patient on warfarin?

A

Stop warfarin.
Give intravenous vitamin K 1-3mg.
Restart warfarin when the INR is less than 5.0.

470
Q

Q: What is the management for an INR between 5.0 and 8.0 without bleeding in a patient on warfarin?

A

Withhold 1 or 2 doses of warfarin.
Reduce the subsequent maintenance dose.

471
Q

Q: Why is prothrombin complex concentrate preferred over fresh frozen plasma (FFP) in cases of intracranial hemorrhage?

A

A: Prothrombin complex concentrate is preferred because FFP can take time to defrost, whereas prothrombin complex concentrate can be administered more quickly.

472
Q

Q: What are the two main types of prosthetic heart valves?

A

A: Biological (bioprosthetic) valves and mechanical valves.

473
Q

Q: What are biological (bioprosthetic) valves typically made from?

A

A: They are usually bovine (cow) or porcine (pig) in origin.

474
Q

Q: What is the major disadvantage of biological (bioprosthetic) valves?

A

A: Structural deterioration and calcification over time.

475
Q

Q: At what age are most patients typically given a bioprosthetic valve?

A

A: Most older patients (> 65 years for aortic valves and > 70 years for mitral valves) receive a bioprosthetic valve.

476
Q

Q: Do patients with biological valves require long-term anticoagulation?

A

A: Long-term anticoagulation is not usually needed, but warfarin may be given for the first 3 months depending on patient factors. Low-dose aspirin is given long-term.

477
Q

Q: What is the most common type of mechanical valve now implanted?

A

A: The bileaflet valve. Ball-and-cage valves are rarely used nowadays.

478
Q

Q: What is the major disadvantage of mechanical valves?

A

A: Increased risk of thrombosis, necessitating long-term anticoagulation.

479
Q

Q: Which anticoagulant is preferred for patients with mechanical heart valves?

A

A: Warfarin is still used in preference to DOACs for patients with mechanical heart valves.

480
Q

Q: According to the 2017 European Society of Cardiology guidelines, when is aspirin given to patients with mechanical valves?

A

A: Aspirin is given only if there is an additional indication, such as ischaemic heart disease.

481
Q

Q: What is the target INR for patients with a mechanical aortic valve?

A

A: The target INR is 3.0.

482
Q

Q: What is the target INR for patients with a mechanical mitral valve?

A

A: The target INR is 3.5.

483
Q

What antithrombotic therapy is given to 1 - bioprosthetic valves and 2 - mechanical valves

A

bioprosthetic: aspirin
mechanical: warfarin + aspirin

484
Q

How do you manage asymptomatic mitral stenosis

A

monitoring - regular echocardiogram every 6-12 months

485
Q

How should you initiate sacubitril-valsartan for heart failure management

A

should be initiated following ACEi or ARB wash-out period

486
Q

What type of murmur is seen in pulmonary stenosis

A

ejection systolic murmur. This murmur is typically heard best in the second left intercostal space and may radiate towards the left shoulder.

487
Q

How do you manage coarctation of aorta in a baby

A

IV prostaglandins to maintain PDA before corrective surgery is done

488
Q

What are side effects of Ivabadrine

A

visual effects, particular luminous phenomena, are common
headache
bradycardia, heart block

489
Q

What ABPM measurement matters more, daytime or night time or combined?

A

daytime

490
Q

What is a contraindication to nitrates

A

aortic stenosis
hypotension (<90)
bradycardia (<50)
treatment for erectile dysfunction (eg sildenafil)

491
Q

What strep group is Streptococcus sanguinis part of

A

strep viridans

492
Q

What can you add second line to heart failure after spiro

A

sglt2 inhibitor

493
Q

Q: When should you refer a patient with suspected ACS to the hospital?

A

Current chest pain or chest pain in the last 12 hours with an abnormal ECG: emergency admission
Chest pain 12-72 hours ago: refer to hospital the same-day for assessment
Chest pain > 72 hours ago: perform full assessment with ECG and troponin measurement before deciding upon further action

494
Q

Q: How does NICE define anginal pain?

A

Constricting discomfort in the front of the chest, or in the neck, shoulders, jaw, or arms
Precipitated by physical exertion
Relieved by rest or GTN in about 5 minutes

495
Q

Q: What are the classifications of anginal pain according to NICE?

A

Typical angina: all 3 features present
Atypical angina: 2 of the 3 features present
Non-anginal chest pain: 1 or none of the features present

496
Q

Q: What is the first-line investigation for stable angina that cannot be excluded by clinical assessment alone?

A

CT coronary angiography

497
Q

Q: What is the second-line investigation for stable angina according to NICE?

A

Non-invasive functional imaging (looking for reversible myocardial ischaemia)

498
Q

Q: What is the third-line investigation for stable angina?

A

Invasive coronary angiography

499
Q

Q: What is Wellen’s syndrome typically caused by?

A

A: High-grade stenosis in the left anterior descending coronary artery.

500
Q

Q: What are the characteristics of a patient’s condition at the time of presentation with Wellen’s syndrome?

A

A: The patient’s pain may have resolved, and cardiac enzymes may be normal or minimally elevated.

501
Q

Q: What are the ECG features of Wellen’s syndrome?

A

Biphasic or deep T wave inversion in leads V2-3
Minimal ST elevation
No Q waves

502
Q

How do we grade murmurs

A

The Levine Scale:
Grade 1 - Very faint murmur, frequently overlooked
Grade 2 - Slight murmur
Grade 3 - Moderate murmur without palpable thrill
Grade 4 - Loud murmur with palpable thrill
Grade 5 - Very loud murmur with extremely palpable thrill. Can be heard with stethoscope edge
Grade 6 - Extremely loud murmur - can be heard without stethoscope touching the chest wall

503
Q

Which heart failure drug causes ototoxicity

A

IV loop diuretics

504
Q

What anginal drug do you avoid in heart failure

A

verapamil

505
Q

How many blood cultures are recommended for infective endocarditis

A

3 sets

506
Q

Q: Why is the use of Amiodarone limited?

A

Very long half-life (20-100 days), requiring loading doses.
Should ideally be given into central veins (causes thrombophlebitis).
Proarrhythmic effects due to lengthening of the QT interval.
Interacts with other drugs (P450 inhibitor), e.g., decreases metabolism of warfarin.
Numerous long-term adverse effects.

507
Q

Q: What should be monitored before starting Amiodarone treatment?

A

A: TFT (thyroid function test), LFT (liver function test), U&E (urea and electrolytes), CXR (chest X-ray).

508
Q

Q: How often should TFT and LFT be monitored in patients taking Amiodarone?

A

A: Every 6 months.

509
Q

Q: What are the adverse effects of Amiodarone?

A

Thyroid dysfunction (hypothyroidism and hyperthyroidism).
Corneal deposits.
Pulmonary fibrosis/pneumonitis.
Liver fibrosis/hepatitis.
Peripheral neuropathy, myopathy.
Photosensitivity.
‘Slate-grey’ appearance.
Thrombophlebitis and injection site reactions.
Bradycardia.
Lengthens QT interval.

510
Q

how is adenosine given for narrow tachycardia

A

IV bolus

511
Q

what do you do if fibrinolysis fails

A

transfer for pci

512
Q

Q: What is another name for Kartagener’s syndrome?

A

A: Primary ciliary dyskinesia.

513
Q

Q: What are the key features of Kartagener’s syndrome?

A

Dextrocardia or complete situs inversus.
Bronchiectasis.
Recurrent sinusitis.
Subfertility (due to diminished sperm motility and defective ciliary action in the fallopian tubes).

514
Q

Q: Why might Kartagener’s syndrome be mentioned frequently in examinations?

A

A: Due to its association with dextrocardia, which can present as ‘quiet heart sounds’ and ‘small volume complexes in lateral leads’.

515
Q

Q: What mnemonic helps remember the clotting factors affected by warfarin?

A

A: 1972 (II, VII, IX, and X).

516
Q

Q: For which conditions is warfarin still used as a first-line treatment?

A

A: Mechanical heart valves.

517
Q

Q: What is the target INR for venous thromboembolism when using warfarin?

A

A: 2.5, and if recurrent, 3.5.

518
Q

Q: What is the target INR for atrial fibrillation when using warfarin?

A

A: 2.5.

519
Q

Q: Name two factors that may potentiate the effect of warfarin.

A

A: Liver disease and P450 enzyme inhibitors (e.g., amiodarone, ciprofloxacin).

520
Q

Q: Name two side effects of warfarin.

A

A: Haemorrhage and skin necrosis.

521
Q

Q: What is a rare but serious side effect of warfarin when it is first started?

A

A: Skin necrosis due to a temporary procoagulant state from reduced protein C biosynthesis.

522
Q

Q: What syndrome may occur involving the feet due to warfarin therapy?

A

A: Purple toes syndrome.

523
Q

What murmur can pulmonary hypertension cause

A

tricuspid regurg

524
Q

murmur heard loudest in the second intercostal space along the left sternal border

A

pulmonary stenosis

525
Q

What drugs should be stopped during c diff infection

A

opiods

526
Q
A